Assurasource Ltd - Medicare Mental Health Clinic in Allen, TX

Assurasource Ltd is a medicare enrolled mental health clinic (Social Worker - Clinical) in Allen, Texas. The current practice location for Assurasource Ltd is 400 N Allen Dr Ste 204, Allen, Texas. For appointments, you can reach them via phone at (972) 233-1010. The mailing address for Assurasource Ltd is 400 N Allen Dr Ste 204, Allen, Texas and phone number is (972) 233-1010.

Assurasource Ltd is licensed to practice in * (Not Available) (license number ). The clinic also participates in the medicare program and its NPI number is 1194746016. This medical practice accepts medicare insurance (which means this clinic accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance). However, please confirm if they accept your insurance at (972) 233-1010.

Contact Information

Assurasource Ltd
400 N Allen Dr Ste 204
Allen
TX 75013-2568
(972) 233-1010
(214) 623-6692

Mental Health Clinic Profile

Full NameAssurasource Ltd
SpecialitySocial Worker
Location400 N Allen Dr Ste 204, Allen, Texas
Authorized Official Name and PositionEmmanuel Sandoval (PRESIDENT)
Authorized Official Contact9722331010
Accepts Medicare InsuranceYes. This clinic participates in medicare program and accept medicare insurance.

Mailing Address and Practice Location

Mailing AddressPractice Location Address
Assurasource Ltd
400 N Allen Dr Ste 204
Allen
TX 75013-2568

Ph: (972) 233-1010
Assurasource Ltd
400 N Allen Dr Ste 204
Allen
TX 75013-2568

Ph: (972) 233-1010

NPI Details:

NPI Number1194746016
Provider Enumeration Date07/23/2006
Last Update Date09/13/2023
Certification Date09/13/2023

Medicare PECOS Information:

Medicare PECOS PAC ID8123125580
Medicare Enrollment IDO20070518000258

News Archive

New Cornell discovery could lead to effective treatment for tuberculosis

A recent discovery by Cornell University researchers could lead to a new, effective treatment for persistent tuberculosis infections.

A new report on health spending by Americans

There have been several studies showing that spending on health by Americans is on the rise, and around 18 percent of the US economy is individual spending on health. A study titled, "US Health Care Spending by Payer and Health Condition, 1996-2016," was published in the latest issue of JAMA today.

Rosetta Genomics reports revenues of $150,000 for full-year 2009

Rosetta Genomics, Ltd., a leading developer of microRNA-based molecular diagnostics, today reported that on March 26, 2010 the Company filed its Form 20-F with the U.S. Securities and Exchange Committee, which contains financial results for the three and 12 months ended December 31, 2009.

Third case of monkey pox confirmed in UK

Officials from Public Health England (PHE) have confirmed yesterday (26th September 2018) that a third person in UK has been diagnosed with monkey pox. While the first two patients had most likely picked up the infection from Nigeria, this third infection has occurred in a healthcare worker who was treating one of the first two infected patients at Blackpool Victoria Hospital.

Johns Hopkins researchers discover oxaliplatin-based nerve damage

Oxaliplatin, a platinum-based anticancer drug that's made enormous headway in recent years against colorectal cancer, appears to cause nerve damage that may be permanent and worsens even months after treatment ends.

Read more Medical News

› Verified 1 days ago

Medical Identifiers

Medical identifiers for Assurasource Ltd such as npi, medicare ID, medicare PIN, medicaid, etc.
IdentifierTypeStateIssuer
1194746016NPI-NPPES
191481401MedicaidTX

Medical Taxonomies and Licenses

TaxonomyTypeLicense (State)Status
1041C0700XSocial Worker - Clinical (* (Not Available))Primary
251S00000XCommunity/behavioral Health (* (Not Available))Secondary

Medicare Reassignments

Some practitioners may not bill the customers directly but medicare billing happens through clinics / group practice / hospitals where the provider works. Assurasource Ltd acts as a billing entity for following providers:
Provider NameKelvin D Mccoy
Provider TypePractitioner - Clinical Social Worker
Provider IdentifiersNPI Number: 1043382542
PECOS PAC ID: 6608780465
Enrollment ID: I20031211000231

News Archive

New Cornell discovery could lead to effective treatment for tuberculosis

A recent discovery by Cornell University researchers could lead to a new, effective treatment for persistent tuberculosis infections.

A new report on health spending by Americans

There have been several studies showing that spending on health by Americans is on the rise, and around 18 percent of the US economy is individual spending on health. A study titled, "US Health Care Spending by Payer and Health Condition, 1996-2016," was published in the latest issue of JAMA today.

Rosetta Genomics reports revenues of $150,000 for full-year 2009

Rosetta Genomics, Ltd., a leading developer of microRNA-based molecular diagnostics, today reported that on March 26, 2010 the Company filed its Form 20-F with the U.S. Securities and Exchange Committee, which contains financial results for the three and 12 months ended December 31, 2009.

Third case of monkey pox confirmed in UK

Officials from Public Health England (PHE) have confirmed yesterday (26th September 2018) that a third person in UK has been diagnosed with monkey pox. While the first two patients had most likely picked up the infection from Nigeria, this third infection has occurred in a healthcare worker who was treating one of the first two infected patients at Blackpool Victoria Hospital.

Johns Hopkins researchers discover oxaliplatin-based nerve damage

Oxaliplatin, a platinum-based anticancer drug that's made enormous headway in recent years against colorectal cancer, appears to cause nerve damage that may be permanent and worsens even months after treatment ends.

Read more Medical News

› Verified 1 days ago

Provider NameMarci Holloway
Provider TypePractitioner - Clinical Social Worker
Provider IdentifiersNPI Number: 1245436435
PECOS PAC ID: 0143129882
Enrollment ID: I20040102000110

News Archive

New Cornell discovery could lead to effective treatment for tuberculosis

A recent discovery by Cornell University researchers could lead to a new, effective treatment for persistent tuberculosis infections.

A new report on health spending by Americans

There have been several studies showing that spending on health by Americans is on the rise, and around 18 percent of the US economy is individual spending on health. A study titled, "US Health Care Spending by Payer and Health Condition, 1996-2016," was published in the latest issue of JAMA today.

Rosetta Genomics reports revenues of $150,000 for full-year 2009

Rosetta Genomics, Ltd., a leading developer of microRNA-based molecular diagnostics, today reported that on March 26, 2010 the Company filed its Form 20-F with the U.S. Securities and Exchange Committee, which contains financial results for the three and 12 months ended December 31, 2009.

Third case of monkey pox confirmed in UK

Officials from Public Health England (PHE) have confirmed yesterday (26th September 2018) that a third person in UK has been diagnosed with monkey pox. While the first two patients had most likely picked up the infection from Nigeria, this third infection has occurred in a healthcare worker who was treating one of the first two infected patients at Blackpool Victoria Hospital.

Johns Hopkins researchers discover oxaliplatin-based nerve damage

Oxaliplatin, a platinum-based anticancer drug that's made enormous headway in recent years against colorectal cancer, appears to cause nerve damage that may be permanent and worsens even months after treatment ends.

Read more Medical News

› Verified 1 days ago

Provider NameMark W Chapman
Provider TypePractitioner - Clinical Social Worker
Provider IdentifiersNPI Number: 1679559819
PECOS PAC ID: 9537055637
Enrollment ID: I20040225000826

News Archive

New Cornell discovery could lead to effective treatment for tuberculosis

A recent discovery by Cornell University researchers could lead to a new, effective treatment for persistent tuberculosis infections.

A new report on health spending by Americans

There have been several studies showing that spending on health by Americans is on the rise, and around 18 percent of the US economy is individual spending on health. A study titled, "US Health Care Spending by Payer and Health Condition, 1996-2016," was published in the latest issue of JAMA today.

Rosetta Genomics reports revenues of $150,000 for full-year 2009

Rosetta Genomics, Ltd., a leading developer of microRNA-based molecular diagnostics, today reported that on March 26, 2010 the Company filed its Form 20-F with the U.S. Securities and Exchange Committee, which contains financial results for the three and 12 months ended December 31, 2009.

Third case of monkey pox confirmed in UK

Officials from Public Health England (PHE) have confirmed yesterday (26th September 2018) that a third person in UK has been diagnosed with monkey pox. While the first two patients had most likely picked up the infection from Nigeria, this third infection has occurred in a healthcare worker who was treating one of the first two infected patients at Blackpool Victoria Hospital.

Johns Hopkins researchers discover oxaliplatin-based nerve damage

Oxaliplatin, a platinum-based anticancer drug that's made enormous headway in recent years against colorectal cancer, appears to cause nerve damage that may be permanent and worsens even months after treatment ends.

Read more Medical News

› Verified 1 days ago

Provider NameGail Arline Martin
Provider TypePractitioner - Clinical Social Worker
Provider IdentifiersNPI Number: 1891984464
PECOS PAC ID: 3476533803
Enrollment ID: I20040724000344

News Archive

New Cornell discovery could lead to effective treatment for tuberculosis

A recent discovery by Cornell University researchers could lead to a new, effective treatment for persistent tuberculosis infections.

A new report on health spending by Americans

There have been several studies showing that spending on health by Americans is on the rise, and around 18 percent of the US economy is individual spending on health. A study titled, "US Health Care Spending by Payer and Health Condition, 1996-2016," was published in the latest issue of JAMA today.

Rosetta Genomics reports revenues of $150,000 for full-year 2009

Rosetta Genomics, Ltd., a leading developer of microRNA-based molecular diagnostics, today reported that on March 26, 2010 the Company filed its Form 20-F with the U.S. Securities and Exchange Committee, which contains financial results for the three and 12 months ended December 31, 2009.

Third case of monkey pox confirmed in UK

Officials from Public Health England (PHE) have confirmed yesterday (26th September 2018) that a third person in UK has been diagnosed with monkey pox. While the first two patients had most likely picked up the infection from Nigeria, this third infection has occurred in a healthcare worker who was treating one of the first two infected patients at Blackpool Victoria Hospital.

Johns Hopkins researchers discover oxaliplatin-based nerve damage

Oxaliplatin, a platinum-based anticancer drug that's made enormous headway in recent years against colorectal cancer, appears to cause nerve damage that may be permanent and worsens even months after treatment ends.

Read more Medical News

› Verified 1 days ago

Provider NameTzivia E Stein
Provider TypePractitioner - Clinical Social Worker
Provider IdentifiersNPI Number: 1255356929
PECOS PAC ID: 3072575414
Enrollment ID: I20041028000824

News Archive

New Cornell discovery could lead to effective treatment for tuberculosis

A recent discovery by Cornell University researchers could lead to a new, effective treatment for persistent tuberculosis infections.

A new report on health spending by Americans

There have been several studies showing that spending on health by Americans is on the rise, and around 18 percent of the US economy is individual spending on health. A study titled, "US Health Care Spending by Payer and Health Condition, 1996-2016," was published in the latest issue of JAMA today.

Rosetta Genomics reports revenues of $150,000 for full-year 2009

Rosetta Genomics, Ltd., a leading developer of microRNA-based molecular diagnostics, today reported that on March 26, 2010 the Company filed its Form 20-F with the U.S. Securities and Exchange Committee, which contains financial results for the three and 12 months ended December 31, 2009.

Third case of monkey pox confirmed in UK

Officials from Public Health England (PHE) have confirmed yesterday (26th September 2018) that a third person in UK has been diagnosed with monkey pox. While the first two patients had most likely picked up the infection from Nigeria, this third infection has occurred in a healthcare worker who was treating one of the first two infected patients at Blackpool Victoria Hospital.

Johns Hopkins researchers discover oxaliplatin-based nerve damage

Oxaliplatin, a platinum-based anticancer drug that's made enormous headway in recent years against colorectal cancer, appears to cause nerve damage that may be permanent and worsens even months after treatment ends.

Read more Medical News

› Verified 1 days ago

Provider NameCynthia A Cashman
Provider TypePractitioner - Clinical Social Worker
Provider IdentifiersNPI Number: 1225251911
PECOS PAC ID: 8325006927
Enrollment ID: I20041229000566

News Archive

New Cornell discovery could lead to effective treatment for tuberculosis

A recent discovery by Cornell University researchers could lead to a new, effective treatment for persistent tuberculosis infections.

A new report on health spending by Americans

There have been several studies showing that spending on health by Americans is on the rise, and around 18 percent of the US economy is individual spending on health. A study titled, "US Health Care Spending by Payer and Health Condition, 1996-2016," was published in the latest issue of JAMA today.

Rosetta Genomics reports revenues of $150,000 for full-year 2009

Rosetta Genomics, Ltd., a leading developer of microRNA-based molecular diagnostics, today reported that on March 26, 2010 the Company filed its Form 20-F with the U.S. Securities and Exchange Committee, which contains financial results for the three and 12 months ended December 31, 2009.

Third case of monkey pox confirmed in UK

Officials from Public Health England (PHE) have confirmed yesterday (26th September 2018) that a third person in UK has been diagnosed with monkey pox. While the first two patients had most likely picked up the infection from Nigeria, this third infection has occurred in a healthcare worker who was treating one of the first two infected patients at Blackpool Victoria Hospital.

Johns Hopkins researchers discover oxaliplatin-based nerve damage

Oxaliplatin, a platinum-based anticancer drug that's made enormous headway in recent years against colorectal cancer, appears to cause nerve damage that may be permanent and worsens even months after treatment ends.

Read more Medical News

› Verified 1 days ago

Provider NameAva L Pickard
Provider TypePractitioner - Clinical Social Worker
Provider IdentifiersNPI Number: 1942495940
PECOS PAC ID: 9032151550
Enrollment ID: I20050525000429

News Archive

New Cornell discovery could lead to effective treatment for tuberculosis

A recent discovery by Cornell University researchers could lead to a new, effective treatment for persistent tuberculosis infections.

A new report on health spending by Americans

There have been several studies showing that spending on health by Americans is on the rise, and around 18 percent of the US economy is individual spending on health. A study titled, "US Health Care Spending by Payer and Health Condition, 1996-2016," was published in the latest issue of JAMA today.

Rosetta Genomics reports revenues of $150,000 for full-year 2009

Rosetta Genomics, Ltd., a leading developer of microRNA-based molecular diagnostics, today reported that on March 26, 2010 the Company filed its Form 20-F with the U.S. Securities and Exchange Committee, which contains financial results for the three and 12 months ended December 31, 2009.

Third case of monkey pox confirmed in UK

Officials from Public Health England (PHE) have confirmed yesterday (26th September 2018) that a third person in UK has been diagnosed with monkey pox. While the first two patients had most likely picked up the infection from Nigeria, this third infection has occurred in a healthcare worker who was treating one of the first two infected patients at Blackpool Victoria Hospital.

Johns Hopkins researchers discover oxaliplatin-based nerve damage

Oxaliplatin, a platinum-based anticancer drug that's made enormous headway in recent years against colorectal cancer, appears to cause nerve damage that may be permanent and worsens even months after treatment ends.

Read more Medical News

› Verified 1 days ago

Provider NameCatherine P Campbell
Provider TypePractitioner - Clinical Social Worker
Provider IdentifiersNPI Number: 1003028713
PECOS PAC ID: 7618999525
Enrollment ID: I20051220000515

News Archive

New Cornell discovery could lead to effective treatment for tuberculosis

A recent discovery by Cornell University researchers could lead to a new, effective treatment for persistent tuberculosis infections.

A new report on health spending by Americans

There have been several studies showing that spending on health by Americans is on the rise, and around 18 percent of the US economy is individual spending on health. A study titled, "US Health Care Spending by Payer and Health Condition, 1996-2016," was published in the latest issue of JAMA today.

Rosetta Genomics reports revenues of $150,000 for full-year 2009

Rosetta Genomics, Ltd., a leading developer of microRNA-based molecular diagnostics, today reported that on March 26, 2010 the Company filed its Form 20-F with the U.S. Securities and Exchange Committee, which contains financial results for the three and 12 months ended December 31, 2009.

Third case of monkey pox confirmed in UK

Officials from Public Health England (PHE) have confirmed yesterday (26th September 2018) that a third person in UK has been diagnosed with monkey pox. While the first two patients had most likely picked up the infection from Nigeria, this third infection has occurred in a healthcare worker who was treating one of the first two infected patients at Blackpool Victoria Hospital.

Johns Hopkins researchers discover oxaliplatin-based nerve damage

Oxaliplatin, a platinum-based anticancer drug that's made enormous headway in recent years against colorectal cancer, appears to cause nerve damage that may be permanent and worsens even months after treatment ends.

Read more Medical News

› Verified 1 days ago

Provider NameErica F Govind Feist
Provider TypePractitioner - Clinical Social Worker
Provider IdentifiersNPI Number: 1518156777
PECOS PAC ID: 2466475645
Enrollment ID: I20060113000546

News Archive

New Cornell discovery could lead to effective treatment for tuberculosis

A recent discovery by Cornell University researchers could lead to a new, effective treatment for persistent tuberculosis infections.

A new report on health spending by Americans

There have been several studies showing that spending on health by Americans is on the rise, and around 18 percent of the US economy is individual spending on health. A study titled, "US Health Care Spending by Payer and Health Condition, 1996-2016," was published in the latest issue of JAMA today.

Rosetta Genomics reports revenues of $150,000 for full-year 2009

Rosetta Genomics, Ltd., a leading developer of microRNA-based molecular diagnostics, today reported that on March 26, 2010 the Company filed its Form 20-F with the U.S. Securities and Exchange Committee, which contains financial results for the three and 12 months ended December 31, 2009.

Third case of monkey pox confirmed in UK

Officials from Public Health England (PHE) have confirmed yesterday (26th September 2018) that a third person in UK has been diagnosed with monkey pox. While the first two patients had most likely picked up the infection from Nigeria, this third infection has occurred in a healthcare worker who was treating one of the first two infected patients at Blackpool Victoria Hospital.

Johns Hopkins researchers discover oxaliplatin-based nerve damage

Oxaliplatin, a platinum-based anticancer drug that's made enormous headway in recent years against colorectal cancer, appears to cause nerve damage that may be permanent and worsens even months after treatment ends.

Read more Medical News

› Verified 1 days ago

Provider NameFrances B Stolarski
Provider TypePractitioner - Clinical Social Worker
Provider IdentifiersNPI Number: 1003911215
PECOS PAC ID: 8325043482
Enrollment ID: I20060922000404

News Archive

New Cornell discovery could lead to effective treatment for tuberculosis

A recent discovery by Cornell University researchers could lead to a new, effective treatment for persistent tuberculosis infections.

A new report on health spending by Americans

There have been several studies showing that spending on health by Americans is on the rise, and around 18 percent of the US economy is individual spending on health. A study titled, "US Health Care Spending by Payer and Health Condition, 1996-2016," was published in the latest issue of JAMA today.

Rosetta Genomics reports revenues of $150,000 for full-year 2009

Rosetta Genomics, Ltd., a leading developer of microRNA-based molecular diagnostics, today reported that on March 26, 2010 the Company filed its Form 20-F with the U.S. Securities and Exchange Committee, which contains financial results for the three and 12 months ended December 31, 2009.

Third case of monkey pox confirmed in UK

Officials from Public Health England (PHE) have confirmed yesterday (26th September 2018) that a third person in UK has been diagnosed with monkey pox. While the first two patients had most likely picked up the infection from Nigeria, this third infection has occurred in a healthcare worker who was treating one of the first two infected patients at Blackpool Victoria Hospital.

Johns Hopkins researchers discover oxaliplatin-based nerve damage

Oxaliplatin, a platinum-based anticancer drug that's made enormous headway in recent years against colorectal cancer, appears to cause nerve damage that may be permanent and worsens even months after treatment ends.

Read more Medical News

› Verified 1 days ago

Provider NameRobin L Gross
Provider TypePractitioner - Clinical Social Worker
Provider IdentifiersNPI Number: 1881637197
PECOS PAC ID: 3678573706
Enrollment ID: I20070116000182

News Archive

New Cornell discovery could lead to effective treatment for tuberculosis

A recent discovery by Cornell University researchers could lead to a new, effective treatment for persistent tuberculosis infections.

A new report on health spending by Americans

There have been several studies showing that spending on health by Americans is on the rise, and around 18 percent of the US economy is individual spending on health. A study titled, "US Health Care Spending by Payer and Health Condition, 1996-2016," was published in the latest issue of JAMA today.

Rosetta Genomics reports revenues of $150,000 for full-year 2009

Rosetta Genomics, Ltd., a leading developer of microRNA-based molecular diagnostics, today reported that on March 26, 2010 the Company filed its Form 20-F with the U.S. Securities and Exchange Committee, which contains financial results for the three and 12 months ended December 31, 2009.

Third case of monkey pox confirmed in UK

Officials from Public Health England (PHE) have confirmed yesterday (26th September 2018) that a third person in UK has been diagnosed with monkey pox. While the first two patients had most likely picked up the infection from Nigeria, this third infection has occurred in a healthcare worker who was treating one of the first two infected patients at Blackpool Victoria Hospital.

Johns Hopkins researchers discover oxaliplatin-based nerve damage

Oxaliplatin, a platinum-based anticancer drug that's made enormous headway in recent years against colorectal cancer, appears to cause nerve damage that may be permanent and worsens even months after treatment ends.

Read more Medical News

› Verified 1 days ago

Provider NameLucinda J Bassili
Provider TypePractitioner - Clinical Social Worker
Provider IdentifiersNPI Number: 1912094327
PECOS PAC ID: 2062504376
Enrollment ID: I20070816000307

News Archive

New Cornell discovery could lead to effective treatment for tuberculosis

A recent discovery by Cornell University researchers could lead to a new, effective treatment for persistent tuberculosis infections.

A new report on health spending by Americans

There have been several studies showing that spending on health by Americans is on the rise, and around 18 percent of the US economy is individual spending on health. A study titled, "US Health Care Spending by Payer and Health Condition, 1996-2016," was published in the latest issue of JAMA today.

Rosetta Genomics reports revenues of $150,000 for full-year 2009

Rosetta Genomics, Ltd., a leading developer of microRNA-based molecular diagnostics, today reported that on March 26, 2010 the Company filed its Form 20-F with the U.S. Securities and Exchange Committee, which contains financial results for the three and 12 months ended December 31, 2009.

Third case of monkey pox confirmed in UK

Officials from Public Health England (PHE) have confirmed yesterday (26th September 2018) that a third person in UK has been diagnosed with monkey pox. While the first two patients had most likely picked up the infection from Nigeria, this third infection has occurred in a healthcare worker who was treating one of the first two infected patients at Blackpool Victoria Hospital.

Johns Hopkins researchers discover oxaliplatin-based nerve damage

Oxaliplatin, a platinum-based anticancer drug that's made enormous headway in recent years against colorectal cancer, appears to cause nerve damage that may be permanent and worsens even months after treatment ends.

Read more Medical News

› Verified 1 days ago

Provider NameSusan Charle Colburn
Provider TypePractitioner - Clinical Social Worker
Provider IdentifiersNPI Number: 1568579126
PECOS PAC ID: 0042296535
Enrollment ID: I20071024000478

News Archive

New Cornell discovery could lead to effective treatment for tuberculosis

A recent discovery by Cornell University researchers could lead to a new, effective treatment for persistent tuberculosis infections.

A new report on health spending by Americans

There have been several studies showing that spending on health by Americans is on the rise, and around 18 percent of the US economy is individual spending on health. A study titled, "US Health Care Spending by Payer and Health Condition, 1996-2016," was published in the latest issue of JAMA today.

Rosetta Genomics reports revenues of $150,000 for full-year 2009

Rosetta Genomics, Ltd., a leading developer of microRNA-based molecular diagnostics, today reported that on March 26, 2010 the Company filed its Form 20-F with the U.S. Securities and Exchange Committee, which contains financial results for the three and 12 months ended December 31, 2009.

Third case of monkey pox confirmed in UK

Officials from Public Health England (PHE) have confirmed yesterday (26th September 2018) that a third person in UK has been diagnosed with monkey pox. While the first two patients had most likely picked up the infection from Nigeria, this third infection has occurred in a healthcare worker who was treating one of the first two infected patients at Blackpool Victoria Hospital.

Johns Hopkins researchers discover oxaliplatin-based nerve damage

Oxaliplatin, a platinum-based anticancer drug that's made enormous headway in recent years against colorectal cancer, appears to cause nerve damage that may be permanent and worsens even months after treatment ends.

Read more Medical News

› Verified 1 days ago

Provider NameRoseann Blann
Provider TypePractitioner - Clinical Social Worker
Provider IdentifiersNPI Number: 1073712931
PECOS PAC ID: 1355421959
Enrollment ID: I20080109000154

News Archive

New Cornell discovery could lead to effective treatment for tuberculosis

A recent discovery by Cornell University researchers could lead to a new, effective treatment for persistent tuberculosis infections.

A new report on health spending by Americans

There have been several studies showing that spending on health by Americans is on the rise, and around 18 percent of the US economy is individual spending on health. A study titled, "US Health Care Spending by Payer and Health Condition, 1996-2016," was published in the latest issue of JAMA today.

Rosetta Genomics reports revenues of $150,000 for full-year 2009

Rosetta Genomics, Ltd., a leading developer of microRNA-based molecular diagnostics, today reported that on March 26, 2010 the Company filed its Form 20-F with the U.S. Securities and Exchange Committee, which contains financial results for the three and 12 months ended December 31, 2009.

Third case of monkey pox confirmed in UK

Officials from Public Health England (PHE) have confirmed yesterday (26th September 2018) that a third person in UK has been diagnosed with monkey pox. While the first two patients had most likely picked up the infection from Nigeria, this third infection has occurred in a healthcare worker who was treating one of the first two infected patients at Blackpool Victoria Hospital.

Johns Hopkins researchers discover oxaliplatin-based nerve damage

Oxaliplatin, a platinum-based anticancer drug that's made enormous headway in recent years against colorectal cancer, appears to cause nerve damage that may be permanent and worsens even months after treatment ends.

Read more Medical News

› Verified 1 days ago

Provider NameJamaica Reyes-araujo
Provider TypePractitioner - Clinical Social Worker
Provider IdentifiersNPI Number: 1407067382
PECOS PAC ID: 6002990322
Enrollment ID: I20080226000391

News Archive

New Cornell discovery could lead to effective treatment for tuberculosis

A recent discovery by Cornell University researchers could lead to a new, effective treatment for persistent tuberculosis infections.

A new report on health spending by Americans

There have been several studies showing that spending on health by Americans is on the rise, and around 18 percent of the US economy is individual spending on health. A study titled, "US Health Care Spending by Payer and Health Condition, 1996-2016," was published in the latest issue of JAMA today.

Rosetta Genomics reports revenues of $150,000 for full-year 2009

Rosetta Genomics, Ltd., a leading developer of microRNA-based molecular diagnostics, today reported that on March 26, 2010 the Company filed its Form 20-F with the U.S. Securities and Exchange Committee, which contains financial results for the three and 12 months ended December 31, 2009.

Third case of monkey pox confirmed in UK

Officials from Public Health England (PHE) have confirmed yesterday (26th September 2018) that a third person in UK has been diagnosed with monkey pox. While the first two patients had most likely picked up the infection from Nigeria, this third infection has occurred in a healthcare worker who was treating one of the first two infected patients at Blackpool Victoria Hospital.

Johns Hopkins researchers discover oxaliplatin-based nerve damage

Oxaliplatin, a platinum-based anticancer drug that's made enormous headway in recent years against colorectal cancer, appears to cause nerve damage that may be permanent and worsens even months after treatment ends.

Read more Medical News

› Verified 1 days ago

Provider NameMary Christine Lochridge
Provider TypePractitioner - Clinical Social Worker
Provider IdentifiersNPI Number: 1659556553
PECOS PAC ID: 4880772292
Enrollment ID: I20080425000411

News Archive

New Cornell discovery could lead to effective treatment for tuberculosis

A recent discovery by Cornell University researchers could lead to a new, effective treatment for persistent tuberculosis infections.

A new report on health spending by Americans

There have been several studies showing that spending on health by Americans is on the rise, and around 18 percent of the US economy is individual spending on health. A study titled, "US Health Care Spending by Payer and Health Condition, 1996-2016," was published in the latest issue of JAMA today.

Rosetta Genomics reports revenues of $150,000 for full-year 2009

Rosetta Genomics, Ltd., a leading developer of microRNA-based molecular diagnostics, today reported that on March 26, 2010 the Company filed its Form 20-F with the U.S. Securities and Exchange Committee, which contains financial results for the three and 12 months ended December 31, 2009.

Third case of monkey pox confirmed in UK

Officials from Public Health England (PHE) have confirmed yesterday (26th September 2018) that a third person in UK has been diagnosed with monkey pox. While the first two patients had most likely picked up the infection from Nigeria, this third infection has occurred in a healthcare worker who was treating one of the first two infected patients at Blackpool Victoria Hospital.

Johns Hopkins researchers discover oxaliplatin-based nerve damage

Oxaliplatin, a platinum-based anticancer drug that's made enormous headway in recent years against colorectal cancer, appears to cause nerve damage that may be permanent and worsens even months after treatment ends.

Read more Medical News

› Verified 1 days ago

Provider NameFrances L Loftis
Provider TypePractitioner - Clinical Social Worker
Provider IdentifiersNPI Number: 1104084169
PECOS PAC ID: 5991878985
Enrollment ID: I20080724000303

News Archive

New Cornell discovery could lead to effective treatment for tuberculosis

A recent discovery by Cornell University researchers could lead to a new, effective treatment for persistent tuberculosis infections.

A new report on health spending by Americans

There have been several studies showing that spending on health by Americans is on the rise, and around 18 percent of the US economy is individual spending on health. A study titled, "US Health Care Spending by Payer and Health Condition, 1996-2016," was published in the latest issue of JAMA today.

Rosetta Genomics reports revenues of $150,000 for full-year 2009

Rosetta Genomics, Ltd., a leading developer of microRNA-based molecular diagnostics, today reported that on March 26, 2010 the Company filed its Form 20-F with the U.S. Securities and Exchange Committee, which contains financial results for the three and 12 months ended December 31, 2009.

Third case of monkey pox confirmed in UK

Officials from Public Health England (PHE) have confirmed yesterday (26th September 2018) that a third person in UK has been diagnosed with monkey pox. While the first two patients had most likely picked up the infection from Nigeria, this third infection has occurred in a healthcare worker who was treating one of the first two infected patients at Blackpool Victoria Hospital.

Johns Hopkins researchers discover oxaliplatin-based nerve damage

Oxaliplatin, a platinum-based anticancer drug that's made enormous headway in recent years against colorectal cancer, appears to cause nerve damage that may be permanent and worsens even months after treatment ends.

Read more Medical News

› Verified 1 days ago

Provider NameLinda Soto
Provider TypePractitioner - Clinical Social Worker
Provider IdentifiersNPI Number: 1003988965
PECOS PAC ID: 6204994411
Enrollment ID: I20081016000383

News Archive

New Cornell discovery could lead to effective treatment for tuberculosis

A recent discovery by Cornell University researchers could lead to a new, effective treatment for persistent tuberculosis infections.

A new report on health spending by Americans

There have been several studies showing that spending on health by Americans is on the rise, and around 18 percent of the US economy is individual spending on health. A study titled, "US Health Care Spending by Payer and Health Condition, 1996-2016," was published in the latest issue of JAMA today.

Rosetta Genomics reports revenues of $150,000 for full-year 2009

Rosetta Genomics, Ltd., a leading developer of microRNA-based molecular diagnostics, today reported that on March 26, 2010 the Company filed its Form 20-F with the U.S. Securities and Exchange Committee, which contains financial results for the three and 12 months ended December 31, 2009.

Third case of monkey pox confirmed in UK

Officials from Public Health England (PHE) have confirmed yesterday (26th September 2018) that a third person in UK has been diagnosed with monkey pox. While the first two patients had most likely picked up the infection from Nigeria, this third infection has occurred in a healthcare worker who was treating one of the first two infected patients at Blackpool Victoria Hospital.

Johns Hopkins researchers discover oxaliplatin-based nerve damage

Oxaliplatin, a platinum-based anticancer drug that's made enormous headway in recent years against colorectal cancer, appears to cause nerve damage that may be permanent and worsens even months after treatment ends.

Read more Medical News

› Verified 1 days ago

Provider NamePaula K Rietz
Provider TypePractitioner - Clinical Social Worker
Provider IdentifiersNPI Number: 1235374653
PECOS PAC ID: 0749345882
Enrollment ID: I20090224000466

News Archive

New Cornell discovery could lead to effective treatment for tuberculosis

A recent discovery by Cornell University researchers could lead to a new, effective treatment for persistent tuberculosis infections.

A new report on health spending by Americans

There have been several studies showing that spending on health by Americans is on the rise, and around 18 percent of the US economy is individual spending on health. A study titled, "US Health Care Spending by Payer and Health Condition, 1996-2016," was published in the latest issue of JAMA today.

Rosetta Genomics reports revenues of $150,000 for full-year 2009

Rosetta Genomics, Ltd., a leading developer of microRNA-based molecular diagnostics, today reported that on March 26, 2010 the Company filed its Form 20-F with the U.S. Securities and Exchange Committee, which contains financial results for the three and 12 months ended December 31, 2009.

Third case of monkey pox confirmed in UK

Officials from Public Health England (PHE) have confirmed yesterday (26th September 2018) that a third person in UK has been diagnosed with monkey pox. While the first two patients had most likely picked up the infection from Nigeria, this third infection has occurred in a healthcare worker who was treating one of the first two infected patients at Blackpool Victoria Hospital.

Johns Hopkins researchers discover oxaliplatin-based nerve damage

Oxaliplatin, a platinum-based anticancer drug that's made enormous headway in recent years against colorectal cancer, appears to cause nerve damage that may be permanent and worsens even months after treatment ends.

Read more Medical News

› Verified 1 days ago

Provider NameLinda J Cone
Provider TypePractitioner - Clinical Social Worker
Provider IdentifiersNPI Number: 1104008671
PECOS PAC ID: 3870659550
Enrollment ID: I20090304000532

News Archive

New Cornell discovery could lead to effective treatment for tuberculosis

A recent discovery by Cornell University researchers could lead to a new, effective treatment for persistent tuberculosis infections.

A new report on health spending by Americans

There have been several studies showing that spending on health by Americans is on the rise, and around 18 percent of the US economy is individual spending on health. A study titled, "US Health Care Spending by Payer and Health Condition, 1996-2016," was published in the latest issue of JAMA today.

Rosetta Genomics reports revenues of $150,000 for full-year 2009

Rosetta Genomics, Ltd., a leading developer of microRNA-based molecular diagnostics, today reported that on March 26, 2010 the Company filed its Form 20-F with the U.S. Securities and Exchange Committee, which contains financial results for the three and 12 months ended December 31, 2009.

Third case of monkey pox confirmed in UK

Officials from Public Health England (PHE) have confirmed yesterday (26th September 2018) that a third person in UK has been diagnosed with monkey pox. While the first two patients had most likely picked up the infection from Nigeria, this third infection has occurred in a healthcare worker who was treating one of the first two infected patients at Blackpool Victoria Hospital.

Johns Hopkins researchers discover oxaliplatin-based nerve damage

Oxaliplatin, a platinum-based anticancer drug that's made enormous headway in recent years against colorectal cancer, appears to cause nerve damage that may be permanent and worsens even months after treatment ends.

Read more Medical News

› Verified 1 days ago

Provider NameFrank Araiza
Provider TypePractitioner - Clinical Social Worker
Provider IdentifiersNPI Number: 1588605844
PECOS PAC ID: 2860559077
Enrollment ID: I20090316000044

News Archive

New Cornell discovery could lead to effective treatment for tuberculosis

A recent discovery by Cornell University researchers could lead to a new, effective treatment for persistent tuberculosis infections.

A new report on health spending by Americans

There have been several studies showing that spending on health by Americans is on the rise, and around 18 percent of the US economy is individual spending on health. A study titled, "US Health Care Spending by Payer and Health Condition, 1996-2016," was published in the latest issue of JAMA today.

Rosetta Genomics reports revenues of $150,000 for full-year 2009

Rosetta Genomics, Ltd., a leading developer of microRNA-based molecular diagnostics, today reported that on March 26, 2010 the Company filed its Form 20-F with the U.S. Securities and Exchange Committee, which contains financial results for the three and 12 months ended December 31, 2009.

Third case of monkey pox confirmed in UK

Officials from Public Health England (PHE) have confirmed yesterday (26th September 2018) that a third person in UK has been diagnosed with monkey pox. While the first two patients had most likely picked up the infection from Nigeria, this third infection has occurred in a healthcare worker who was treating one of the first two infected patients at Blackpool Victoria Hospital.

Johns Hopkins researchers discover oxaliplatin-based nerve damage

Oxaliplatin, a platinum-based anticancer drug that's made enormous headway in recent years against colorectal cancer, appears to cause nerve damage that may be permanent and worsens even months after treatment ends.

Read more Medical News

› Verified 1 days ago

Provider NameSandra S Brackenridge
Provider TypePractitioner - Clinical Social Worker
Provider IdentifiersNPI Number: 1235368705
PECOS PAC ID: 8628121001
Enrollment ID: I20090803000242

News Archive

New Cornell discovery could lead to effective treatment for tuberculosis

A recent discovery by Cornell University researchers could lead to a new, effective treatment for persistent tuberculosis infections.

A new report on health spending by Americans

There have been several studies showing that spending on health by Americans is on the rise, and around 18 percent of the US economy is individual spending on health. A study titled, "US Health Care Spending by Payer and Health Condition, 1996-2016," was published in the latest issue of JAMA today.

Rosetta Genomics reports revenues of $150,000 for full-year 2009

Rosetta Genomics, Ltd., a leading developer of microRNA-based molecular diagnostics, today reported that on March 26, 2010 the Company filed its Form 20-F with the U.S. Securities and Exchange Committee, which contains financial results for the three and 12 months ended December 31, 2009.

Third case of monkey pox confirmed in UK

Officials from Public Health England (PHE) have confirmed yesterday (26th September 2018) that a third person in UK has been diagnosed with monkey pox. While the first two patients had most likely picked up the infection from Nigeria, this third infection has occurred in a healthcare worker who was treating one of the first two infected patients at Blackpool Victoria Hospital.

Johns Hopkins researchers discover oxaliplatin-based nerve damage

Oxaliplatin, a platinum-based anticancer drug that's made enormous headway in recent years against colorectal cancer, appears to cause nerve damage that may be permanent and worsens even months after treatment ends.

Read more Medical News

› Verified 1 days ago

Provider NameJames E Ballenger
Provider TypePractitioner - Clinical Social Worker
Provider IdentifiersNPI Number: 1730202466
PECOS PAC ID: 3779639927
Enrollment ID: I20090914000341

News Archive

New Cornell discovery could lead to effective treatment for tuberculosis

A recent discovery by Cornell University researchers could lead to a new, effective treatment for persistent tuberculosis infections.

A new report on health spending by Americans

There have been several studies showing that spending on health by Americans is on the rise, and around 18 percent of the US economy is individual spending on health. A study titled, "US Health Care Spending by Payer and Health Condition, 1996-2016," was published in the latest issue of JAMA today.

Rosetta Genomics reports revenues of $150,000 for full-year 2009

Rosetta Genomics, Ltd., a leading developer of microRNA-based molecular diagnostics, today reported that on March 26, 2010 the Company filed its Form 20-F with the U.S. Securities and Exchange Committee, which contains financial results for the three and 12 months ended December 31, 2009.

Third case of monkey pox confirmed in UK

Officials from Public Health England (PHE) have confirmed yesterday (26th September 2018) that a third person in UK has been diagnosed with monkey pox. While the first two patients had most likely picked up the infection from Nigeria, this third infection has occurred in a healthcare worker who was treating one of the first two infected patients at Blackpool Victoria Hospital.

Johns Hopkins researchers discover oxaliplatin-based nerve damage

Oxaliplatin, a platinum-based anticancer drug that's made enormous headway in recent years against colorectal cancer, appears to cause nerve damage that may be permanent and worsens even months after treatment ends.

Read more Medical News

› Verified 1 days ago

Provider NameSteven Dequeant
Provider TypePractitioner - Clinical Social Worker
Provider IdentifiersNPI Number: 1851573604
PECOS PAC ID: 5597802074
Enrollment ID: I20091103000087

News Archive

New Cornell discovery could lead to effective treatment for tuberculosis

A recent discovery by Cornell University researchers could lead to a new, effective treatment for persistent tuberculosis infections.

A new report on health spending by Americans

There have been several studies showing that spending on health by Americans is on the rise, and around 18 percent of the US economy is individual spending on health. A study titled, "US Health Care Spending by Payer and Health Condition, 1996-2016," was published in the latest issue of JAMA today.

Rosetta Genomics reports revenues of $150,000 for full-year 2009

Rosetta Genomics, Ltd., a leading developer of microRNA-based molecular diagnostics, today reported that on March 26, 2010 the Company filed its Form 20-F with the U.S. Securities and Exchange Committee, which contains financial results for the three and 12 months ended December 31, 2009.

Third case of monkey pox confirmed in UK

Officials from Public Health England (PHE) have confirmed yesterday (26th September 2018) that a third person in UK has been diagnosed with monkey pox. While the first two patients had most likely picked up the infection from Nigeria, this third infection has occurred in a healthcare worker who was treating one of the first two infected patients at Blackpool Victoria Hospital.

Johns Hopkins researchers discover oxaliplatin-based nerve damage

Oxaliplatin, a platinum-based anticancer drug that's made enormous headway in recent years against colorectal cancer, appears to cause nerve damage that may be permanent and worsens even months after treatment ends.

Read more Medical News

› Verified 1 days ago

Provider NameEdward A Green
Provider TypePractitioner - Clinical Social Worker
Provider IdentifiersNPI Number: 1639171515
PECOS PAC ID: 3870634850
Enrollment ID: I20100427000417

News Archive

New Cornell discovery could lead to effective treatment for tuberculosis

A recent discovery by Cornell University researchers could lead to a new, effective treatment for persistent tuberculosis infections.

A new report on health spending by Americans

There have been several studies showing that spending on health by Americans is on the rise, and around 18 percent of the US economy is individual spending on health. A study titled, "US Health Care Spending by Payer and Health Condition, 1996-2016," was published in the latest issue of JAMA today.

Rosetta Genomics reports revenues of $150,000 for full-year 2009

Rosetta Genomics, Ltd., a leading developer of microRNA-based molecular diagnostics, today reported that on March 26, 2010 the Company filed its Form 20-F with the U.S. Securities and Exchange Committee, which contains financial results for the three and 12 months ended December 31, 2009.

Third case of monkey pox confirmed in UK

Officials from Public Health England (PHE) have confirmed yesterday (26th September 2018) that a third person in UK has been diagnosed with monkey pox. While the first two patients had most likely picked up the infection from Nigeria, this third infection has occurred in a healthcare worker who was treating one of the first two infected patients at Blackpool Victoria Hospital.

Johns Hopkins researchers discover oxaliplatin-based nerve damage

Oxaliplatin, a platinum-based anticancer drug that's made enormous headway in recent years against colorectal cancer, appears to cause nerve damage that may be permanent and worsens even months after treatment ends.

Read more Medical News

› Verified 1 days ago

Provider NamePhillip Hawkins
Provider TypePractitioner - Clinical Social Worker
Provider IdentifiersNPI Number: 1225350259
PECOS PAC ID: 2860520038
Enrollment ID: I20100507000715

News Archive

New Cornell discovery could lead to effective treatment for tuberculosis

A recent discovery by Cornell University researchers could lead to a new, effective treatment for persistent tuberculosis infections.

A new report on health spending by Americans

There have been several studies showing that spending on health by Americans is on the rise, and around 18 percent of the US economy is individual spending on health. A study titled, "US Health Care Spending by Payer and Health Condition, 1996-2016," was published in the latest issue of JAMA today.

Rosetta Genomics reports revenues of $150,000 for full-year 2009

Rosetta Genomics, Ltd., a leading developer of microRNA-based molecular diagnostics, today reported that on March 26, 2010 the Company filed its Form 20-F with the U.S. Securities and Exchange Committee, which contains financial results for the three and 12 months ended December 31, 2009.

Third case of monkey pox confirmed in UK

Officials from Public Health England (PHE) have confirmed yesterday (26th September 2018) that a third person in UK has been diagnosed with monkey pox. While the first two patients had most likely picked up the infection from Nigeria, this third infection has occurred in a healthcare worker who was treating one of the first two infected patients at Blackpool Victoria Hospital.

Johns Hopkins researchers discover oxaliplatin-based nerve damage

Oxaliplatin, a platinum-based anticancer drug that's made enormous headway in recent years against colorectal cancer, appears to cause nerve damage that may be permanent and worsens even months after treatment ends.

Read more Medical News

› Verified 1 days ago

Provider NameDavid Cory
Provider TypePractitioner - Clinical Social Worker
Provider IdentifiersNPI Number: 1629390844
PECOS PAC ID: 4789713520
Enrollment ID: I20100603000631

News Archive

New Cornell discovery could lead to effective treatment for tuberculosis

A recent discovery by Cornell University researchers could lead to a new, effective treatment for persistent tuberculosis infections.

A new report on health spending by Americans

There have been several studies showing that spending on health by Americans is on the rise, and around 18 percent of the US economy is individual spending on health. A study titled, "US Health Care Spending by Payer and Health Condition, 1996-2016," was published in the latest issue of JAMA today.

Rosetta Genomics reports revenues of $150,000 for full-year 2009

Rosetta Genomics, Ltd., a leading developer of microRNA-based molecular diagnostics, today reported that on March 26, 2010 the Company filed its Form 20-F with the U.S. Securities and Exchange Committee, which contains financial results for the three and 12 months ended December 31, 2009.

Third case of monkey pox confirmed in UK

Officials from Public Health England (PHE) have confirmed yesterday (26th September 2018) that a third person in UK has been diagnosed with monkey pox. While the first two patients had most likely picked up the infection from Nigeria, this third infection has occurred in a healthcare worker who was treating one of the first two infected patients at Blackpool Victoria Hospital.

Johns Hopkins researchers discover oxaliplatin-based nerve damage

Oxaliplatin, a platinum-based anticancer drug that's made enormous headway in recent years against colorectal cancer, appears to cause nerve damage that may be permanent and worsens even months after treatment ends.

Read more Medical News

› Verified 1 days ago

Provider NameBarbara Williamson
Provider TypePractitioner - Clinical Social Worker
Provider IdentifiersNPI Number: 1487864211
PECOS PAC ID: 2062542129
Enrollment ID: I20100616000411

News Archive

New Cornell discovery could lead to effective treatment for tuberculosis

A recent discovery by Cornell University researchers could lead to a new, effective treatment for persistent tuberculosis infections.

A new report on health spending by Americans

There have been several studies showing that spending on health by Americans is on the rise, and around 18 percent of the US economy is individual spending on health. A study titled, "US Health Care Spending by Payer and Health Condition, 1996-2016," was published in the latest issue of JAMA today.

Rosetta Genomics reports revenues of $150,000 for full-year 2009

Rosetta Genomics, Ltd., a leading developer of microRNA-based molecular diagnostics, today reported that on March 26, 2010 the Company filed its Form 20-F with the U.S. Securities and Exchange Committee, which contains financial results for the three and 12 months ended December 31, 2009.

Third case of monkey pox confirmed in UK

Officials from Public Health England (PHE) have confirmed yesterday (26th September 2018) that a third person in UK has been diagnosed with monkey pox. While the first two patients had most likely picked up the infection from Nigeria, this third infection has occurred in a healthcare worker who was treating one of the first two infected patients at Blackpool Victoria Hospital.

Johns Hopkins researchers discover oxaliplatin-based nerve damage

Oxaliplatin, a platinum-based anticancer drug that's made enormous headway in recent years against colorectal cancer, appears to cause nerve damage that may be permanent and worsens even months after treatment ends.

Read more Medical News

› Verified 1 days ago

Provider NameTraci Alisia Perry
Provider TypePractitioner - Clinical Social Worker
Provider IdentifiersNPI Number: 1215125497
PECOS PAC ID: 4981886462
Enrollment ID: I20110303000884

News Archive

New Cornell discovery could lead to effective treatment for tuberculosis

A recent discovery by Cornell University researchers could lead to a new, effective treatment for persistent tuberculosis infections.

A new report on health spending by Americans

There have been several studies showing that spending on health by Americans is on the rise, and around 18 percent of the US economy is individual spending on health. A study titled, "US Health Care Spending by Payer and Health Condition, 1996-2016," was published in the latest issue of JAMA today.

Rosetta Genomics reports revenues of $150,000 for full-year 2009

Rosetta Genomics, Ltd., a leading developer of microRNA-based molecular diagnostics, today reported that on March 26, 2010 the Company filed its Form 20-F with the U.S. Securities and Exchange Committee, which contains financial results for the three and 12 months ended December 31, 2009.

Third case of monkey pox confirmed in UK

Officials from Public Health England (PHE) have confirmed yesterday (26th September 2018) that a third person in UK has been diagnosed with monkey pox. While the first two patients had most likely picked up the infection from Nigeria, this third infection has occurred in a healthcare worker who was treating one of the first two infected patients at Blackpool Victoria Hospital.

Johns Hopkins researchers discover oxaliplatin-based nerve damage

Oxaliplatin, a platinum-based anticancer drug that's made enormous headway in recent years against colorectal cancer, appears to cause nerve damage that may be permanent and worsens even months after treatment ends.

Read more Medical News

› Verified 1 days ago

Provider NameDorian Lebeau
Provider TypePractitioner - Clinical Social Worker
Provider IdentifiersNPI Number: 1285754473
PECOS PAC ID: 9436331188
Enrollment ID: I20110316000919

News Archive

New Cornell discovery could lead to effective treatment for tuberculosis

A recent discovery by Cornell University researchers could lead to a new, effective treatment for persistent tuberculosis infections.

A new report on health spending by Americans

There have been several studies showing that spending on health by Americans is on the rise, and around 18 percent of the US economy is individual spending on health. A study titled, "US Health Care Spending by Payer and Health Condition, 1996-2016," was published in the latest issue of JAMA today.

Rosetta Genomics reports revenues of $150,000 for full-year 2009

Rosetta Genomics, Ltd., a leading developer of microRNA-based molecular diagnostics, today reported that on March 26, 2010 the Company filed its Form 20-F with the U.S. Securities and Exchange Committee, which contains financial results for the three and 12 months ended December 31, 2009.

Third case of monkey pox confirmed in UK

Officials from Public Health England (PHE) have confirmed yesterday (26th September 2018) that a third person in UK has been diagnosed with monkey pox. While the first two patients had most likely picked up the infection from Nigeria, this third infection has occurred in a healthcare worker who was treating one of the first two infected patients at Blackpool Victoria Hospital.

Johns Hopkins researchers discover oxaliplatin-based nerve damage

Oxaliplatin, a platinum-based anticancer drug that's made enormous headway in recent years against colorectal cancer, appears to cause nerve damage that may be permanent and worsens even months after treatment ends.

Read more Medical News

› Verified 1 days ago

Provider NameStephanie Marie Gomez
Provider TypePractitioner - Clinical Social Worker
Provider IdentifiersNPI Number: 1699071969
PECOS PAC ID: 1456534197
Enrollment ID: I20110317000871

News Archive

New Cornell discovery could lead to effective treatment for tuberculosis

A recent discovery by Cornell University researchers could lead to a new, effective treatment for persistent tuberculosis infections.

A new report on health spending by Americans

There have been several studies showing that spending on health by Americans is on the rise, and around 18 percent of the US economy is individual spending on health. A study titled, "US Health Care Spending by Payer and Health Condition, 1996-2016," was published in the latest issue of JAMA today.

Rosetta Genomics reports revenues of $150,000 for full-year 2009

Rosetta Genomics, Ltd., a leading developer of microRNA-based molecular diagnostics, today reported that on March 26, 2010 the Company filed its Form 20-F with the U.S. Securities and Exchange Committee, which contains financial results for the three and 12 months ended December 31, 2009.

Third case of monkey pox confirmed in UK

Officials from Public Health England (PHE) have confirmed yesterday (26th September 2018) that a third person in UK has been diagnosed with monkey pox. While the first two patients had most likely picked up the infection from Nigeria, this third infection has occurred in a healthcare worker who was treating one of the first two infected patients at Blackpool Victoria Hospital.

Johns Hopkins researchers discover oxaliplatin-based nerve damage

Oxaliplatin, a platinum-based anticancer drug that's made enormous headway in recent years against colorectal cancer, appears to cause nerve damage that may be permanent and worsens even months after treatment ends.

Read more Medical News

› Verified 1 days ago

Provider NameTamu Mckinney
Provider TypePractitioner - Clinical Social Worker
Provider IdentifiersNPI Number: 1346556701
PECOS PAC ID: 8022291996
Enrollment ID: I20110330000743

News Archive

New Cornell discovery could lead to effective treatment for tuberculosis

A recent discovery by Cornell University researchers could lead to a new, effective treatment for persistent tuberculosis infections.

A new report on health spending by Americans

There have been several studies showing that spending on health by Americans is on the rise, and around 18 percent of the US economy is individual spending on health. A study titled, "US Health Care Spending by Payer and Health Condition, 1996-2016," was published in the latest issue of JAMA today.

Rosetta Genomics reports revenues of $150,000 for full-year 2009

Rosetta Genomics, Ltd., a leading developer of microRNA-based molecular diagnostics, today reported that on March 26, 2010 the Company filed its Form 20-F with the U.S. Securities and Exchange Committee, which contains financial results for the three and 12 months ended December 31, 2009.

Third case of monkey pox confirmed in UK

Officials from Public Health England (PHE) have confirmed yesterday (26th September 2018) that a third person in UK has been diagnosed with monkey pox. While the first two patients had most likely picked up the infection from Nigeria, this third infection has occurred in a healthcare worker who was treating one of the first two infected patients at Blackpool Victoria Hospital.

Johns Hopkins researchers discover oxaliplatin-based nerve damage

Oxaliplatin, a platinum-based anticancer drug that's made enormous headway in recent years against colorectal cancer, appears to cause nerve damage that may be permanent and worsens even months after treatment ends.

Read more Medical News

› Verified 1 days ago

Provider NameDavid T Marsden
Provider TypePractitioner - Clinical Social Worker
Provider IdentifiersNPI Number: 1659308765
PECOS PAC ID: 5698952182
Enrollment ID: I20110609000712

News Archive

New Cornell discovery could lead to effective treatment for tuberculosis

A recent discovery by Cornell University researchers could lead to a new, effective treatment for persistent tuberculosis infections.

A new report on health spending by Americans

There have been several studies showing that spending on health by Americans is on the rise, and around 18 percent of the US economy is individual spending on health. A study titled, "US Health Care Spending by Payer and Health Condition, 1996-2016," was published in the latest issue of JAMA today.

Rosetta Genomics reports revenues of $150,000 for full-year 2009

Rosetta Genomics, Ltd., a leading developer of microRNA-based molecular diagnostics, today reported that on March 26, 2010 the Company filed its Form 20-F with the U.S. Securities and Exchange Committee, which contains financial results for the three and 12 months ended December 31, 2009.

Third case of monkey pox confirmed in UK

Officials from Public Health England (PHE) have confirmed yesterday (26th September 2018) that a third person in UK has been diagnosed with monkey pox. While the first two patients had most likely picked up the infection from Nigeria, this third infection has occurred in a healthcare worker who was treating one of the first two infected patients at Blackpool Victoria Hospital.

Johns Hopkins researchers discover oxaliplatin-based nerve damage

Oxaliplatin, a platinum-based anticancer drug that's made enormous headway in recent years against colorectal cancer, appears to cause nerve damage that may be permanent and worsens even months after treatment ends.

Read more Medical News

› Verified 1 days ago

Provider NameKimberly J Rumczikas
Provider TypePractitioner - Clinical Social Worker
Provider IdentifiersNPI Number: 1457551079
PECOS PAC ID: 7012195241
Enrollment ID: I20110616000834

News Archive

New Cornell discovery could lead to effective treatment for tuberculosis

A recent discovery by Cornell University researchers could lead to a new, effective treatment for persistent tuberculosis infections.

A new report on health spending by Americans

There have been several studies showing that spending on health by Americans is on the rise, and around 18 percent of the US economy is individual spending on health. A study titled, "US Health Care Spending by Payer and Health Condition, 1996-2016," was published in the latest issue of JAMA today.

Rosetta Genomics reports revenues of $150,000 for full-year 2009

Rosetta Genomics, Ltd., a leading developer of microRNA-based molecular diagnostics, today reported that on March 26, 2010 the Company filed its Form 20-F with the U.S. Securities and Exchange Committee, which contains financial results for the three and 12 months ended December 31, 2009.

Third case of monkey pox confirmed in UK

Officials from Public Health England (PHE) have confirmed yesterday (26th September 2018) that a third person in UK has been diagnosed with monkey pox. While the first two patients had most likely picked up the infection from Nigeria, this third infection has occurred in a healthcare worker who was treating one of the first two infected patients at Blackpool Victoria Hospital.

Johns Hopkins researchers discover oxaliplatin-based nerve damage

Oxaliplatin, a platinum-based anticancer drug that's made enormous headway in recent years against colorectal cancer, appears to cause nerve damage that may be permanent and worsens even months after treatment ends.

Read more Medical News

› Verified 1 days ago

Provider NameBrenda June Casey
Provider TypePractitioner - Clinical Social Worker
Provider IdentifiersNPI Number: 1831487800
PECOS PAC ID: 0648442053
Enrollment ID: I20111007000054

News Archive

New Cornell discovery could lead to effective treatment for tuberculosis

A recent discovery by Cornell University researchers could lead to a new, effective treatment for persistent tuberculosis infections.

A new report on health spending by Americans

There have been several studies showing that spending on health by Americans is on the rise, and around 18 percent of the US economy is individual spending on health. A study titled, "US Health Care Spending by Payer and Health Condition, 1996-2016," was published in the latest issue of JAMA today.

Rosetta Genomics reports revenues of $150,000 for full-year 2009

Rosetta Genomics, Ltd., a leading developer of microRNA-based molecular diagnostics, today reported that on March 26, 2010 the Company filed its Form 20-F with the U.S. Securities and Exchange Committee, which contains financial results for the three and 12 months ended December 31, 2009.

Third case of monkey pox confirmed in UK

Officials from Public Health England (PHE) have confirmed yesterday (26th September 2018) that a third person in UK has been diagnosed with monkey pox. While the first two patients had most likely picked up the infection from Nigeria, this third infection has occurred in a healthcare worker who was treating one of the first two infected patients at Blackpool Victoria Hospital.

Johns Hopkins researchers discover oxaliplatin-based nerve damage

Oxaliplatin, a platinum-based anticancer drug that's made enormous headway in recent years against colorectal cancer, appears to cause nerve damage that may be permanent and worsens even months after treatment ends.

Read more Medical News

› Verified 1 days ago

Provider NameTomasita Espinosa
Provider TypePractitioner - Clinical Social Worker
Provider IdentifiersNPI Number: 1477669729
PECOS PAC ID: 8820255227
Enrollment ID: I20120213000269

News Archive

New Cornell discovery could lead to effective treatment for tuberculosis

A recent discovery by Cornell University researchers could lead to a new, effective treatment for persistent tuberculosis infections.

A new report on health spending by Americans

There have been several studies showing that spending on health by Americans is on the rise, and around 18 percent of the US economy is individual spending on health. A study titled, "US Health Care Spending by Payer and Health Condition, 1996-2016," was published in the latest issue of JAMA today.

Rosetta Genomics reports revenues of $150,000 for full-year 2009

Rosetta Genomics, Ltd., a leading developer of microRNA-based molecular diagnostics, today reported that on March 26, 2010 the Company filed its Form 20-F with the U.S. Securities and Exchange Committee, which contains financial results for the three and 12 months ended December 31, 2009.

Third case of monkey pox confirmed in UK

Officials from Public Health England (PHE) have confirmed yesterday (26th September 2018) that a third person in UK has been diagnosed with monkey pox. While the first two patients had most likely picked up the infection from Nigeria, this third infection has occurred in a healthcare worker who was treating one of the first two infected patients at Blackpool Victoria Hospital.

Johns Hopkins researchers discover oxaliplatin-based nerve damage

Oxaliplatin, a platinum-based anticancer drug that's made enormous headway in recent years against colorectal cancer, appears to cause nerve damage that may be permanent and worsens even months after treatment ends.

Read more Medical News

› Verified 1 days ago

Provider NameSandra J King
Provider TypePractitioner - Clinical Social Worker
Provider IdentifiersNPI Number: 1275805301
PECOS PAC ID: 4587826318
Enrollment ID: I20120424000444

News Archive

New Cornell discovery could lead to effective treatment for tuberculosis

A recent discovery by Cornell University researchers could lead to a new, effective treatment for persistent tuberculosis infections.

A new report on health spending by Americans

There have been several studies showing that spending on health by Americans is on the rise, and around 18 percent of the US economy is individual spending on health. A study titled, "US Health Care Spending by Payer and Health Condition, 1996-2016," was published in the latest issue of JAMA today.

Rosetta Genomics reports revenues of $150,000 for full-year 2009

Rosetta Genomics, Ltd., a leading developer of microRNA-based molecular diagnostics, today reported that on March 26, 2010 the Company filed its Form 20-F with the U.S. Securities and Exchange Committee, which contains financial results for the three and 12 months ended December 31, 2009.

Third case of monkey pox confirmed in UK

Officials from Public Health England (PHE) have confirmed yesterday (26th September 2018) that a third person in UK has been diagnosed with monkey pox. While the first two patients had most likely picked up the infection from Nigeria, this third infection has occurred in a healthcare worker who was treating one of the first two infected patients at Blackpool Victoria Hospital.

Johns Hopkins researchers discover oxaliplatin-based nerve damage

Oxaliplatin, a platinum-based anticancer drug that's made enormous headway in recent years against colorectal cancer, appears to cause nerve damage that may be permanent and worsens even months after treatment ends.

Read more Medical News

› Verified 1 days ago

Provider NameSuzanne James
Provider TypePractitioner - Clinical Social Worker
Provider IdentifiersNPI Number: 1639440563
PECOS PAC ID: 3274796602
Enrollment ID: I20120523000325

News Archive

New Cornell discovery could lead to effective treatment for tuberculosis

A recent discovery by Cornell University researchers could lead to a new, effective treatment for persistent tuberculosis infections.

A new report on health spending by Americans

There have been several studies showing that spending on health by Americans is on the rise, and around 18 percent of the US economy is individual spending on health. A study titled, "US Health Care Spending by Payer and Health Condition, 1996-2016," was published in the latest issue of JAMA today.

Rosetta Genomics reports revenues of $150,000 for full-year 2009

Rosetta Genomics, Ltd., a leading developer of microRNA-based molecular diagnostics, today reported that on March 26, 2010 the Company filed its Form 20-F with the U.S. Securities and Exchange Committee, which contains financial results for the three and 12 months ended December 31, 2009.

Third case of monkey pox confirmed in UK

Officials from Public Health England (PHE) have confirmed yesterday (26th September 2018) that a third person in UK has been diagnosed with monkey pox. While the first two patients had most likely picked up the infection from Nigeria, this third infection has occurred in a healthcare worker who was treating one of the first two infected patients at Blackpool Victoria Hospital.

Johns Hopkins researchers discover oxaliplatin-based nerve damage

Oxaliplatin, a platinum-based anticancer drug that's made enormous headway in recent years against colorectal cancer, appears to cause nerve damage that may be permanent and worsens even months after treatment ends.

Read more Medical News

› Verified 1 days ago

Provider NameVirginia Flores
Provider TypePractitioner - Clinical Social Worker
Provider IdentifiersNPI Number: 1356608087
PECOS PAC ID: 7719141787
Enrollment ID: I20120605000076

News Archive

New Cornell discovery could lead to effective treatment for tuberculosis

A recent discovery by Cornell University researchers could lead to a new, effective treatment for persistent tuberculosis infections.

A new report on health spending by Americans

There have been several studies showing that spending on health by Americans is on the rise, and around 18 percent of the US economy is individual spending on health. A study titled, "US Health Care Spending by Payer and Health Condition, 1996-2016," was published in the latest issue of JAMA today.

Rosetta Genomics reports revenues of $150,000 for full-year 2009

Rosetta Genomics, Ltd., a leading developer of microRNA-based molecular diagnostics, today reported that on March 26, 2010 the Company filed its Form 20-F with the U.S. Securities and Exchange Committee, which contains financial results for the three and 12 months ended December 31, 2009.

Third case of monkey pox confirmed in UK

Officials from Public Health England (PHE) have confirmed yesterday (26th September 2018) that a third person in UK has been diagnosed with monkey pox. While the first two patients had most likely picked up the infection from Nigeria, this third infection has occurred in a healthcare worker who was treating one of the first two infected patients at Blackpool Victoria Hospital.

Johns Hopkins researchers discover oxaliplatin-based nerve damage

Oxaliplatin, a platinum-based anticancer drug that's made enormous headway in recent years against colorectal cancer, appears to cause nerve damage that may be permanent and worsens even months after treatment ends.

Read more Medical News

› Verified 1 days ago

Provider NameElizabeth Rodriguez Srouji
Provider TypePractitioner - Clinical Social Worker
Provider IdentifiersNPI Number: 1821351149
PECOS PAC ID: 6800047499
Enrollment ID: I20121107000467

News Archive

New Cornell discovery could lead to effective treatment for tuberculosis

A recent discovery by Cornell University researchers could lead to a new, effective treatment for persistent tuberculosis infections.

A new report on health spending by Americans

There have been several studies showing that spending on health by Americans is on the rise, and around 18 percent of the US economy is individual spending on health. A study titled, "US Health Care Spending by Payer and Health Condition, 1996-2016," was published in the latest issue of JAMA today.

Rosetta Genomics reports revenues of $150,000 for full-year 2009

Rosetta Genomics, Ltd., a leading developer of microRNA-based molecular diagnostics, today reported that on March 26, 2010 the Company filed its Form 20-F with the U.S. Securities and Exchange Committee, which contains financial results for the three and 12 months ended December 31, 2009.

Third case of monkey pox confirmed in UK

Officials from Public Health England (PHE) have confirmed yesterday (26th September 2018) that a third person in UK has been diagnosed with monkey pox. While the first two patients had most likely picked up the infection from Nigeria, this third infection has occurred in a healthcare worker who was treating one of the first two infected patients at Blackpool Victoria Hospital.

Johns Hopkins researchers discover oxaliplatin-based nerve damage

Oxaliplatin, a platinum-based anticancer drug that's made enormous headway in recent years against colorectal cancer, appears to cause nerve damage that may be permanent and worsens even months after treatment ends.

Read more Medical News

› Verified 1 days ago

Provider NameCourtney Paige Smith
Provider TypePractitioner - Clinical Social Worker
Provider IdentifiersNPI Number: 1326384926
PECOS PAC ID: 6709023849
Enrollment ID: I20130509000556

News Archive

New Cornell discovery could lead to effective treatment for tuberculosis

A recent discovery by Cornell University researchers could lead to a new, effective treatment for persistent tuberculosis infections.

A new report on health spending by Americans

There have been several studies showing that spending on health by Americans is on the rise, and around 18 percent of the US economy is individual spending on health. A study titled, "US Health Care Spending by Payer and Health Condition, 1996-2016," was published in the latest issue of JAMA today.

Rosetta Genomics reports revenues of $150,000 for full-year 2009

Rosetta Genomics, Ltd., a leading developer of microRNA-based molecular diagnostics, today reported that on March 26, 2010 the Company filed its Form 20-F with the U.S. Securities and Exchange Committee, which contains financial results for the three and 12 months ended December 31, 2009.

Third case of monkey pox confirmed in UK

Officials from Public Health England (PHE) have confirmed yesterday (26th September 2018) that a third person in UK has been diagnosed with monkey pox. While the first two patients had most likely picked up the infection from Nigeria, this third infection has occurred in a healthcare worker who was treating one of the first two infected patients at Blackpool Victoria Hospital.

Johns Hopkins researchers discover oxaliplatin-based nerve damage

Oxaliplatin, a platinum-based anticancer drug that's made enormous headway in recent years against colorectal cancer, appears to cause nerve damage that may be permanent and worsens even months after treatment ends.

Read more Medical News

› Verified 1 days ago

Provider NameJose Antonio Gonzales
Provider TypePractitioner - Clinical Social Worker
Provider IdentifiersNPI Number: 1386939049
PECOS PAC ID: 4587833488
Enrollment ID: I20130613000183

News Archive

New Cornell discovery could lead to effective treatment for tuberculosis

A recent discovery by Cornell University researchers could lead to a new, effective treatment for persistent tuberculosis infections.

A new report on health spending by Americans

There have been several studies showing that spending on health by Americans is on the rise, and around 18 percent of the US economy is individual spending on health. A study titled, "US Health Care Spending by Payer and Health Condition, 1996-2016," was published in the latest issue of JAMA today.

Rosetta Genomics reports revenues of $150,000 for full-year 2009

Rosetta Genomics, Ltd., a leading developer of microRNA-based molecular diagnostics, today reported that on March 26, 2010 the Company filed its Form 20-F with the U.S. Securities and Exchange Committee, which contains financial results for the three and 12 months ended December 31, 2009.

Third case of monkey pox confirmed in UK

Officials from Public Health England (PHE) have confirmed yesterday (26th September 2018) that a third person in UK has been diagnosed with monkey pox. While the first two patients had most likely picked up the infection from Nigeria, this third infection has occurred in a healthcare worker who was treating one of the first two infected patients at Blackpool Victoria Hospital.

Johns Hopkins researchers discover oxaliplatin-based nerve damage

Oxaliplatin, a platinum-based anticancer drug that's made enormous headway in recent years against colorectal cancer, appears to cause nerve damage that may be permanent and worsens even months after treatment ends.

Read more Medical News

› Verified 1 days ago

Provider NameEnedina E Enriquez
Provider TypePractitioner - Clinical Social Worker
Provider IdentifiersNPI Number: 1891704052
PECOS PAC ID: 6103821244
Enrollment ID: I20130816000814

News Archive

New Cornell discovery could lead to effective treatment for tuberculosis

A recent discovery by Cornell University researchers could lead to a new, effective treatment for persistent tuberculosis infections.

A new report on health spending by Americans

There have been several studies showing that spending on health by Americans is on the rise, and around 18 percent of the US economy is individual spending on health. A study titled, "US Health Care Spending by Payer and Health Condition, 1996-2016," was published in the latest issue of JAMA today.

Rosetta Genomics reports revenues of $150,000 for full-year 2009

Rosetta Genomics, Ltd., a leading developer of microRNA-based molecular diagnostics, today reported that on March 26, 2010 the Company filed its Form 20-F with the U.S. Securities and Exchange Committee, which contains financial results for the three and 12 months ended December 31, 2009.

Third case of monkey pox confirmed in UK

Officials from Public Health England (PHE) have confirmed yesterday (26th September 2018) that a third person in UK has been diagnosed with monkey pox. While the first two patients had most likely picked up the infection from Nigeria, this third infection has occurred in a healthcare worker who was treating one of the first two infected patients at Blackpool Victoria Hospital.

Johns Hopkins researchers discover oxaliplatin-based nerve damage

Oxaliplatin, a platinum-based anticancer drug that's made enormous headway in recent years against colorectal cancer, appears to cause nerve damage that may be permanent and worsens even months after treatment ends.

Read more Medical News

› Verified 1 days ago

Provider NameMitchell Hill
Provider TypePractitioner - Clinical Social Worker
Provider IdentifiersNPI Number: 1790123610
PECOS PAC ID: 1355576406
Enrollment ID: I20131028001370

News Archive

New Cornell discovery could lead to effective treatment for tuberculosis

A recent discovery by Cornell University researchers could lead to a new, effective treatment for persistent tuberculosis infections.

A new report on health spending by Americans

There have been several studies showing that spending on health by Americans is on the rise, and around 18 percent of the US economy is individual spending on health. A study titled, "US Health Care Spending by Payer and Health Condition, 1996-2016," was published in the latest issue of JAMA today.

Rosetta Genomics reports revenues of $150,000 for full-year 2009

Rosetta Genomics, Ltd., a leading developer of microRNA-based molecular diagnostics, today reported that on March 26, 2010 the Company filed its Form 20-F with the U.S. Securities and Exchange Committee, which contains financial results for the three and 12 months ended December 31, 2009.

Third case of monkey pox confirmed in UK

Officials from Public Health England (PHE) have confirmed yesterday (26th September 2018) that a third person in UK has been diagnosed with monkey pox. While the first two patients had most likely picked up the infection from Nigeria, this third infection has occurred in a healthcare worker who was treating one of the first two infected patients at Blackpool Victoria Hospital.

Johns Hopkins researchers discover oxaliplatin-based nerve damage

Oxaliplatin, a platinum-based anticancer drug that's made enormous headway in recent years against colorectal cancer, appears to cause nerve damage that may be permanent and worsens even months after treatment ends.

Read more Medical News

› Verified 1 days ago

Provider NameMary C Travis
Provider TypePractitioner - Clinical Social Worker
Provider IdentifiersNPI Number: 1932522729
PECOS PAC ID: 2567695596
Enrollment ID: I20140429000178

News Archive

New Cornell discovery could lead to effective treatment for tuberculosis

A recent discovery by Cornell University researchers could lead to a new, effective treatment for persistent tuberculosis infections.

A new report on health spending by Americans

There have been several studies showing that spending on health by Americans is on the rise, and around 18 percent of the US economy is individual spending on health. A study titled, "US Health Care Spending by Payer and Health Condition, 1996-2016," was published in the latest issue of JAMA today.

Rosetta Genomics reports revenues of $150,000 for full-year 2009

Rosetta Genomics, Ltd., a leading developer of microRNA-based molecular diagnostics, today reported that on March 26, 2010 the Company filed its Form 20-F with the U.S. Securities and Exchange Committee, which contains financial results for the three and 12 months ended December 31, 2009.

Third case of monkey pox confirmed in UK

Officials from Public Health England (PHE) have confirmed yesterday (26th September 2018) that a third person in UK has been diagnosed with monkey pox. While the first two patients had most likely picked up the infection from Nigeria, this third infection has occurred in a healthcare worker who was treating one of the first two infected patients at Blackpool Victoria Hospital.

Johns Hopkins researchers discover oxaliplatin-based nerve damage

Oxaliplatin, a platinum-based anticancer drug that's made enormous headway in recent years against colorectal cancer, appears to cause nerve damage that may be permanent and worsens even months after treatment ends.

Read more Medical News

› Verified 1 days ago

Provider NameRebecca K Walker
Provider TypePractitioner - Clinical Social Worker
Provider IdentifiersNPI Number: 1760802391
PECOS PAC ID: 6406071935
Enrollment ID: I20140625002128

News Archive

New Cornell discovery could lead to effective treatment for tuberculosis

A recent discovery by Cornell University researchers could lead to a new, effective treatment for persistent tuberculosis infections.

A new report on health spending by Americans

There have been several studies showing that spending on health by Americans is on the rise, and around 18 percent of the US economy is individual spending on health. A study titled, "US Health Care Spending by Payer and Health Condition, 1996-2016," was published in the latest issue of JAMA today.

Rosetta Genomics reports revenues of $150,000 for full-year 2009

Rosetta Genomics, Ltd., a leading developer of microRNA-based molecular diagnostics, today reported that on March 26, 2010 the Company filed its Form 20-F with the U.S. Securities and Exchange Committee, which contains financial results for the three and 12 months ended December 31, 2009.

Third case of monkey pox confirmed in UK

Officials from Public Health England (PHE) have confirmed yesterday (26th September 2018) that a third person in UK has been diagnosed with monkey pox. While the first two patients had most likely picked up the infection from Nigeria, this third infection has occurred in a healthcare worker who was treating one of the first two infected patients at Blackpool Victoria Hospital.

Johns Hopkins researchers discover oxaliplatin-based nerve damage

Oxaliplatin, a platinum-based anticancer drug that's made enormous headway in recent years against colorectal cancer, appears to cause nerve damage that may be permanent and worsens even months after treatment ends.

Read more Medical News

› Verified 1 days ago

Provider NameChristie Moore
Provider TypePractitioner - Clinical Social Worker
Provider IdentifiersNPI Number: 1831500222
PECOS PAC ID: 3577788868
Enrollment ID: I20140630000640

News Archive

New Cornell discovery could lead to effective treatment for tuberculosis

A recent discovery by Cornell University researchers could lead to a new, effective treatment for persistent tuberculosis infections.

A new report on health spending by Americans

There have been several studies showing that spending on health by Americans is on the rise, and around 18 percent of the US economy is individual spending on health. A study titled, "US Health Care Spending by Payer and Health Condition, 1996-2016," was published in the latest issue of JAMA today.

Rosetta Genomics reports revenues of $150,000 for full-year 2009

Rosetta Genomics, Ltd., a leading developer of microRNA-based molecular diagnostics, today reported that on March 26, 2010 the Company filed its Form 20-F with the U.S. Securities and Exchange Committee, which contains financial results for the three and 12 months ended December 31, 2009.

Third case of monkey pox confirmed in UK

Officials from Public Health England (PHE) have confirmed yesterday (26th September 2018) that a third person in UK has been diagnosed with monkey pox. While the first two patients had most likely picked up the infection from Nigeria, this third infection has occurred in a healthcare worker who was treating one of the first two infected patients at Blackpool Victoria Hospital.

Johns Hopkins researchers discover oxaliplatin-based nerve damage

Oxaliplatin, a platinum-based anticancer drug that's made enormous headway in recent years against colorectal cancer, appears to cause nerve damage that may be permanent and worsens even months after treatment ends.

Read more Medical News

› Verified 1 days ago

Provider NameCherissa R Mcconnell
Provider TypePractitioner - Clinical Social Worker
Provider IdentifiersNPI Number: 1255733028
PECOS PAC ID: 4981926284
Enrollment ID: I20141121001848

News Archive

New Cornell discovery could lead to effective treatment for tuberculosis

A recent discovery by Cornell University researchers could lead to a new, effective treatment for persistent tuberculosis infections.

A new report on health spending by Americans

There have been several studies showing that spending on health by Americans is on the rise, and around 18 percent of the US economy is individual spending on health. A study titled, "US Health Care Spending by Payer and Health Condition, 1996-2016," was published in the latest issue of JAMA today.

Rosetta Genomics reports revenues of $150,000 for full-year 2009

Rosetta Genomics, Ltd., a leading developer of microRNA-based molecular diagnostics, today reported that on March 26, 2010 the Company filed its Form 20-F with the U.S. Securities and Exchange Committee, which contains financial results for the three and 12 months ended December 31, 2009.

Third case of monkey pox confirmed in UK

Officials from Public Health England (PHE) have confirmed yesterday (26th September 2018) that a third person in UK has been diagnosed with monkey pox. While the first two patients had most likely picked up the infection from Nigeria, this third infection has occurred in a healthcare worker who was treating one of the first two infected patients at Blackpool Victoria Hospital.

Johns Hopkins researchers discover oxaliplatin-based nerve damage

Oxaliplatin, a platinum-based anticancer drug that's made enormous headway in recent years against colorectal cancer, appears to cause nerve damage that may be permanent and worsens even months after treatment ends.

Read more Medical News

› Verified 1 days ago

Provider NameJulie Dimock
Provider TypePractitioner - Clinical Social Worker
Provider IdentifiersNPI Number: 1225427974
PECOS PAC ID: 6305161878
Enrollment ID: I20150205000465

News Archive

New Cornell discovery could lead to effective treatment for tuberculosis

A recent discovery by Cornell University researchers could lead to a new, effective treatment for persistent tuberculosis infections.

A new report on health spending by Americans

There have been several studies showing that spending on health by Americans is on the rise, and around 18 percent of the US economy is individual spending on health. A study titled, "US Health Care Spending by Payer and Health Condition, 1996-2016," was published in the latest issue of JAMA today.

Rosetta Genomics reports revenues of $150,000 for full-year 2009

Rosetta Genomics, Ltd., a leading developer of microRNA-based molecular diagnostics, today reported that on March 26, 2010 the Company filed its Form 20-F with the U.S. Securities and Exchange Committee, which contains financial results for the three and 12 months ended December 31, 2009.

Third case of monkey pox confirmed in UK

Officials from Public Health England (PHE) have confirmed yesterday (26th September 2018) that a third person in UK has been diagnosed with monkey pox. While the first two patients had most likely picked up the infection from Nigeria, this third infection has occurred in a healthcare worker who was treating one of the first two infected patients at Blackpool Victoria Hospital.

Johns Hopkins researchers discover oxaliplatin-based nerve damage

Oxaliplatin, a platinum-based anticancer drug that's made enormous headway in recent years against colorectal cancer, appears to cause nerve damage that may be permanent and worsens even months after treatment ends.

Read more Medical News

› Verified 1 days ago

Provider NameFelicia A Humphery
Provider TypePractitioner - Clinical Social Worker
Provider IdentifiersNPI Number: 1417143348
PECOS PAC ID: 0648596668
Enrollment ID: I20150310000083

News Archive

New Cornell discovery could lead to effective treatment for tuberculosis

A recent discovery by Cornell University researchers could lead to a new, effective treatment for persistent tuberculosis infections.

A new report on health spending by Americans

There have been several studies showing that spending on health by Americans is on the rise, and around 18 percent of the US economy is individual spending on health. A study titled, "US Health Care Spending by Payer and Health Condition, 1996-2016," was published in the latest issue of JAMA today.

Rosetta Genomics reports revenues of $150,000 for full-year 2009

Rosetta Genomics, Ltd., a leading developer of microRNA-based molecular diagnostics, today reported that on March 26, 2010 the Company filed its Form 20-F with the U.S. Securities and Exchange Committee, which contains financial results for the three and 12 months ended December 31, 2009.

Third case of monkey pox confirmed in UK

Officials from Public Health England (PHE) have confirmed yesterday (26th September 2018) that a third person in UK has been diagnosed with monkey pox. While the first two patients had most likely picked up the infection from Nigeria, this third infection has occurred in a healthcare worker who was treating one of the first two infected patients at Blackpool Victoria Hospital.

Johns Hopkins researchers discover oxaliplatin-based nerve damage

Oxaliplatin, a platinum-based anticancer drug that's made enormous headway in recent years against colorectal cancer, appears to cause nerve damage that may be permanent and worsens even months after treatment ends.

Read more Medical News

› Verified 1 days ago

Provider NameBruce Turk
Provider TypePractitioner - Clinical Social Worker
Provider IdentifiersNPI Number: 1912145442
PECOS PAC ID: 0941366934
Enrollment ID: I20151023001027

News Archive

New Cornell discovery could lead to effective treatment for tuberculosis

A recent discovery by Cornell University researchers could lead to a new, effective treatment for persistent tuberculosis infections.

A new report on health spending by Americans

There have been several studies showing that spending on health by Americans is on the rise, and around 18 percent of the US economy is individual spending on health. A study titled, "US Health Care Spending by Payer and Health Condition, 1996-2016," was published in the latest issue of JAMA today.

Rosetta Genomics reports revenues of $150,000 for full-year 2009

Rosetta Genomics, Ltd., a leading developer of microRNA-based molecular diagnostics, today reported that on March 26, 2010 the Company filed its Form 20-F with the U.S. Securities and Exchange Committee, which contains financial results for the three and 12 months ended December 31, 2009.

Third case of monkey pox confirmed in UK

Officials from Public Health England (PHE) have confirmed yesterday (26th September 2018) that a third person in UK has been diagnosed with monkey pox. While the first two patients had most likely picked up the infection from Nigeria, this third infection has occurred in a healthcare worker who was treating one of the first two infected patients at Blackpool Victoria Hospital.

Johns Hopkins researchers discover oxaliplatin-based nerve damage

Oxaliplatin, a platinum-based anticancer drug that's made enormous headway in recent years against colorectal cancer, appears to cause nerve damage that may be permanent and worsens even months after treatment ends.

Read more Medical News

› Verified 1 days ago

Provider NameTrue Hardt
Provider TypePractitioner - Clinical Social Worker
Provider IdentifiersNPI Number: 1821443342
PECOS PAC ID: 5991099228
Enrollment ID: I20160810001023

News Archive

New Cornell discovery could lead to effective treatment for tuberculosis

A recent discovery by Cornell University researchers could lead to a new, effective treatment for persistent tuberculosis infections.

A new report on health spending by Americans

There have been several studies showing that spending on health by Americans is on the rise, and around 18 percent of the US economy is individual spending on health. A study titled, "US Health Care Spending by Payer and Health Condition, 1996-2016," was published in the latest issue of JAMA today.

Rosetta Genomics reports revenues of $150,000 for full-year 2009

Rosetta Genomics, Ltd., a leading developer of microRNA-based molecular diagnostics, today reported that on March 26, 2010 the Company filed its Form 20-F with the U.S. Securities and Exchange Committee, which contains financial results for the three and 12 months ended December 31, 2009.

Third case of monkey pox confirmed in UK

Officials from Public Health England (PHE) have confirmed yesterday (26th September 2018) that a third person in UK has been diagnosed with monkey pox. While the first two patients had most likely picked up the infection from Nigeria, this third infection has occurred in a healthcare worker who was treating one of the first two infected patients at Blackpool Victoria Hospital.

Johns Hopkins researchers discover oxaliplatin-based nerve damage

Oxaliplatin, a platinum-based anticancer drug that's made enormous headway in recent years against colorectal cancer, appears to cause nerve damage that may be permanent and worsens even months after treatment ends.

Read more Medical News

› Verified 1 days ago

Provider NameErica Harris
Provider TypePractitioner - Clinical Social Worker
Provider IdentifiersNPI Number: 1497140073
PECOS PAC ID: 8325335037
Enrollment ID: I20160923001306

News Archive

New Cornell discovery could lead to effective treatment for tuberculosis

A recent discovery by Cornell University researchers could lead to a new, effective treatment for persistent tuberculosis infections.

A new report on health spending by Americans

There have been several studies showing that spending on health by Americans is on the rise, and around 18 percent of the US economy is individual spending on health. A study titled, "US Health Care Spending by Payer and Health Condition, 1996-2016," was published in the latest issue of JAMA today.

Rosetta Genomics reports revenues of $150,000 for full-year 2009

Rosetta Genomics, Ltd., a leading developer of microRNA-based molecular diagnostics, today reported that on March 26, 2010 the Company filed its Form 20-F with the U.S. Securities and Exchange Committee, which contains financial results for the three and 12 months ended December 31, 2009.

Third case of monkey pox confirmed in UK

Officials from Public Health England (PHE) have confirmed yesterday (26th September 2018) that a third person in UK has been diagnosed with monkey pox. While the first two patients had most likely picked up the infection from Nigeria, this third infection has occurred in a healthcare worker who was treating one of the first two infected patients at Blackpool Victoria Hospital.

Johns Hopkins researchers discover oxaliplatin-based nerve damage

Oxaliplatin, a platinum-based anticancer drug that's made enormous headway in recent years against colorectal cancer, appears to cause nerve damage that may be permanent and worsens even months after treatment ends.

Read more Medical News

› Verified 1 days ago

Provider NameArtie Williams
Provider TypePractitioner - Clinical Social Worker
Provider IdentifiersNPI Number: 1871801639
PECOS PAC ID: 0749577112
Enrollment ID: I20160928002185

News Archive

New Cornell discovery could lead to effective treatment for tuberculosis

A recent discovery by Cornell University researchers could lead to a new, effective treatment for persistent tuberculosis infections.

A new report on health spending by Americans

There have been several studies showing that spending on health by Americans is on the rise, and around 18 percent of the US economy is individual spending on health. A study titled, "US Health Care Spending by Payer and Health Condition, 1996-2016," was published in the latest issue of JAMA today.

Rosetta Genomics reports revenues of $150,000 for full-year 2009

Rosetta Genomics, Ltd., a leading developer of microRNA-based molecular diagnostics, today reported that on March 26, 2010 the Company filed its Form 20-F with the U.S. Securities and Exchange Committee, which contains financial results for the three and 12 months ended December 31, 2009.

Third case of monkey pox confirmed in UK

Officials from Public Health England (PHE) have confirmed yesterday (26th September 2018) that a third person in UK has been diagnosed with monkey pox. While the first two patients had most likely picked up the infection from Nigeria, this third infection has occurred in a healthcare worker who was treating one of the first two infected patients at Blackpool Victoria Hospital.

Johns Hopkins researchers discover oxaliplatin-based nerve damage

Oxaliplatin, a platinum-based anticancer drug that's made enormous headway in recent years against colorectal cancer, appears to cause nerve damage that may be permanent and worsens even months after treatment ends.

Read more Medical News

› Verified 1 days ago

Provider NameHarriet L Cohen
Provider TypePractitioner - Clinical Social Worker
Provider IdentifiersNPI Number: 1720535982
PECOS PAC ID: 7618265257
Enrollment ID: I20161013001316

News Archive

New Cornell discovery could lead to effective treatment for tuberculosis

A recent discovery by Cornell University researchers could lead to a new, effective treatment for persistent tuberculosis infections.

A new report on health spending by Americans

There have been several studies showing that spending on health by Americans is on the rise, and around 18 percent of the US economy is individual spending on health. A study titled, "US Health Care Spending by Payer and Health Condition, 1996-2016," was published in the latest issue of JAMA today.

Rosetta Genomics reports revenues of $150,000 for full-year 2009

Rosetta Genomics, Ltd., a leading developer of microRNA-based molecular diagnostics, today reported that on March 26, 2010 the Company filed its Form 20-F with the U.S. Securities and Exchange Committee, which contains financial results for the three and 12 months ended December 31, 2009.

Third case of monkey pox confirmed in UK

Officials from Public Health England (PHE) have confirmed yesterday (26th September 2018) that a third person in UK has been diagnosed with monkey pox. While the first two patients had most likely picked up the infection from Nigeria, this third infection has occurred in a healthcare worker who was treating one of the first two infected patients at Blackpool Victoria Hospital.

Johns Hopkins researchers discover oxaliplatin-based nerve damage

Oxaliplatin, a platinum-based anticancer drug that's made enormous headway in recent years against colorectal cancer, appears to cause nerve damage that may be permanent and worsens even months after treatment ends.

Read more Medical News

› Verified 1 days ago

Provider NameAudra Johnson
Provider TypePractitioner - Clinical Social Worker
Provider IdentifiersNPI Number: 1477936581
PECOS PAC ID: 0547548851
Enrollment ID: I20161020000961

News Archive

New Cornell discovery could lead to effective treatment for tuberculosis

A recent discovery by Cornell University researchers could lead to a new, effective treatment for persistent tuberculosis infections.

A new report on health spending by Americans

There have been several studies showing that spending on health by Americans is on the rise, and around 18 percent of the US economy is individual spending on health. A study titled, "US Health Care Spending by Payer and Health Condition, 1996-2016," was published in the latest issue of JAMA today.

Rosetta Genomics reports revenues of $150,000 for full-year 2009

Rosetta Genomics, Ltd., a leading developer of microRNA-based molecular diagnostics, today reported that on March 26, 2010 the Company filed its Form 20-F with the U.S. Securities and Exchange Committee, which contains financial results for the three and 12 months ended December 31, 2009.

Third case of monkey pox confirmed in UK

Officials from Public Health England (PHE) have confirmed yesterday (26th September 2018) that a third person in UK has been diagnosed with monkey pox. While the first two patients had most likely picked up the infection from Nigeria, this third infection has occurred in a healthcare worker who was treating one of the first two infected patients at Blackpool Victoria Hospital.

Johns Hopkins researchers discover oxaliplatin-based nerve damage

Oxaliplatin, a platinum-based anticancer drug that's made enormous headway in recent years against colorectal cancer, appears to cause nerve damage that may be permanent and worsens even months after treatment ends.

Read more Medical News

› Verified 1 days ago

Provider NamePhillip Alan Hieger
Provider TypePractitioner - Clinical Social Worker
Provider IdentifiersNPI Number: 1275084642
PECOS PAC ID: 9931264652
Enrollment ID: I20161114000453

News Archive

New Cornell discovery could lead to effective treatment for tuberculosis

A recent discovery by Cornell University researchers could lead to a new, effective treatment for persistent tuberculosis infections.

A new report on health spending by Americans

There have been several studies showing that spending on health by Americans is on the rise, and around 18 percent of the US economy is individual spending on health. A study titled, "US Health Care Spending by Payer and Health Condition, 1996-2016," was published in the latest issue of JAMA today.

Rosetta Genomics reports revenues of $150,000 for full-year 2009

Rosetta Genomics, Ltd., a leading developer of microRNA-based molecular diagnostics, today reported that on March 26, 2010 the Company filed its Form 20-F with the U.S. Securities and Exchange Committee, which contains financial results for the three and 12 months ended December 31, 2009.

Third case of monkey pox confirmed in UK

Officials from Public Health England (PHE) have confirmed yesterday (26th September 2018) that a third person in UK has been diagnosed with monkey pox. While the first two patients had most likely picked up the infection from Nigeria, this third infection has occurred in a healthcare worker who was treating one of the first two infected patients at Blackpool Victoria Hospital.

Johns Hopkins researchers discover oxaliplatin-based nerve damage

Oxaliplatin, a platinum-based anticancer drug that's made enormous headway in recent years against colorectal cancer, appears to cause nerve damage that may be permanent and worsens even months after treatment ends.

Read more Medical News

› Verified 1 days ago

Provider NameRoman Gabriel Venegas
Provider TypePractitioner - Clinical Social Worker
Provider IdentifiersNPI Number: 1467704783
PECOS PAC ID: 0840579991
Enrollment ID: I20161114002079

News Archive

New Cornell discovery could lead to effective treatment for tuberculosis

A recent discovery by Cornell University researchers could lead to a new, effective treatment for persistent tuberculosis infections.

A new report on health spending by Americans

There have been several studies showing that spending on health by Americans is on the rise, and around 18 percent of the US economy is individual spending on health. A study titled, "US Health Care Spending by Payer and Health Condition, 1996-2016," was published in the latest issue of JAMA today.

Rosetta Genomics reports revenues of $150,000 for full-year 2009

Rosetta Genomics, Ltd., a leading developer of microRNA-based molecular diagnostics, today reported that on March 26, 2010 the Company filed its Form 20-F with the U.S. Securities and Exchange Committee, which contains financial results for the three and 12 months ended December 31, 2009.

Third case of monkey pox confirmed in UK

Officials from Public Health England (PHE) have confirmed yesterday (26th September 2018) that a third person in UK has been diagnosed with monkey pox. While the first two patients had most likely picked up the infection from Nigeria, this third infection has occurred in a healthcare worker who was treating one of the first two infected patients at Blackpool Victoria Hospital.

Johns Hopkins researchers discover oxaliplatin-based nerve damage

Oxaliplatin, a platinum-based anticancer drug that's made enormous headway in recent years against colorectal cancer, appears to cause nerve damage that may be permanent and worsens even months after treatment ends.

Read more Medical News

› Verified 1 days ago

Provider NameRamona Roston
Provider TypePractitioner - Clinical Social Worker
Provider IdentifiersNPI Number: 1487106209
PECOS PAC ID: 4981984317
Enrollment ID: I20161201000376

News Archive

New Cornell discovery could lead to effective treatment for tuberculosis

A recent discovery by Cornell University researchers could lead to a new, effective treatment for persistent tuberculosis infections.

A new report on health spending by Americans

There have been several studies showing that spending on health by Americans is on the rise, and around 18 percent of the US economy is individual spending on health. A study titled, "US Health Care Spending by Payer and Health Condition, 1996-2016," was published in the latest issue of JAMA today.

Rosetta Genomics reports revenues of $150,000 for full-year 2009

Rosetta Genomics, Ltd., a leading developer of microRNA-based molecular diagnostics, today reported that on March 26, 2010 the Company filed its Form 20-F with the U.S. Securities and Exchange Committee, which contains financial results for the three and 12 months ended December 31, 2009.

Third case of monkey pox confirmed in UK

Officials from Public Health England (PHE) have confirmed yesterday (26th September 2018) that a third person in UK has been diagnosed with monkey pox. While the first two patients had most likely picked up the infection from Nigeria, this third infection has occurred in a healthcare worker who was treating one of the first two infected patients at Blackpool Victoria Hospital.

Johns Hopkins researchers discover oxaliplatin-based nerve damage

Oxaliplatin, a platinum-based anticancer drug that's made enormous headway in recent years against colorectal cancer, appears to cause nerve damage that may be permanent and worsens even months after treatment ends.

Read more Medical News

› Verified 1 days ago

Provider NameEleanor L Burt
Provider TypePractitioner - Clinical Social Worker
Provider IdentifiersNPI Number: 1275080046
PECOS PAC ID: 9032491352
Enrollment ID: I20170123000703

News Archive

New Cornell discovery could lead to effective treatment for tuberculosis

A recent discovery by Cornell University researchers could lead to a new, effective treatment for persistent tuberculosis infections.

A new report on health spending by Americans

There have been several studies showing that spending on health by Americans is on the rise, and around 18 percent of the US economy is individual spending on health. A study titled, "US Health Care Spending by Payer and Health Condition, 1996-2016," was published in the latest issue of JAMA today.

Rosetta Genomics reports revenues of $150,000 for full-year 2009

Rosetta Genomics, Ltd., a leading developer of microRNA-based molecular diagnostics, today reported that on March 26, 2010 the Company filed its Form 20-F with the U.S. Securities and Exchange Committee, which contains financial results for the three and 12 months ended December 31, 2009.

Third case of monkey pox confirmed in UK

Officials from Public Health England (PHE) have confirmed yesterday (26th September 2018) that a third person in UK has been diagnosed with monkey pox. While the first two patients had most likely picked up the infection from Nigeria, this third infection has occurred in a healthcare worker who was treating one of the first two infected patients at Blackpool Victoria Hospital.

Johns Hopkins researchers discover oxaliplatin-based nerve damage

Oxaliplatin, a platinum-based anticancer drug that's made enormous headway in recent years against colorectal cancer, appears to cause nerve damage that may be permanent and worsens even months after treatment ends.

Read more Medical News

› Verified 1 days ago

Provider NameNikaria S Mccray
Provider TypePractitioner - Clinical Social Worker
Provider IdentifiersNPI Number: 1396284279
PECOS PAC ID: 4183908544
Enrollment ID: I20170302000655

News Archive

New Cornell discovery could lead to effective treatment for tuberculosis

A recent discovery by Cornell University researchers could lead to a new, effective treatment for persistent tuberculosis infections.

A new report on health spending by Americans

There have been several studies showing that spending on health by Americans is on the rise, and around 18 percent of the US economy is individual spending on health. A study titled, "US Health Care Spending by Payer and Health Condition, 1996-2016," was published in the latest issue of JAMA today.

Rosetta Genomics reports revenues of $150,000 for full-year 2009

Rosetta Genomics, Ltd., a leading developer of microRNA-based molecular diagnostics, today reported that on March 26, 2010 the Company filed its Form 20-F with the U.S. Securities and Exchange Committee, which contains financial results for the three and 12 months ended December 31, 2009.

Third case of monkey pox confirmed in UK

Officials from Public Health England (PHE) have confirmed yesterday (26th September 2018) that a third person in UK has been diagnosed with monkey pox. While the first two patients had most likely picked up the infection from Nigeria, this third infection has occurred in a healthcare worker who was treating one of the first two infected patients at Blackpool Victoria Hospital.

Johns Hopkins researchers discover oxaliplatin-based nerve damage

Oxaliplatin, a platinum-based anticancer drug that's made enormous headway in recent years against colorectal cancer, appears to cause nerve damage that may be permanent and worsens even months after treatment ends.

Read more Medical News

› Verified 1 days ago

Provider NameGeorge Devejian
Provider TypePractitioner - Clinical Social Worker
Provider IdentifiersNPI Number: 1780135988
PECOS PAC ID: 9032493259
Enrollment ID: I20170307000132

News Archive

New Cornell discovery could lead to effective treatment for tuberculosis

A recent discovery by Cornell University researchers could lead to a new, effective treatment for persistent tuberculosis infections.

A new report on health spending by Americans

There have been several studies showing that spending on health by Americans is on the rise, and around 18 percent of the US economy is individual spending on health. A study titled, "US Health Care Spending by Payer and Health Condition, 1996-2016," was published in the latest issue of JAMA today.

Rosetta Genomics reports revenues of $150,000 for full-year 2009

Rosetta Genomics, Ltd., a leading developer of microRNA-based molecular diagnostics, today reported that on March 26, 2010 the Company filed its Form 20-F with the U.S. Securities and Exchange Committee, which contains financial results for the three and 12 months ended December 31, 2009.

Third case of monkey pox confirmed in UK

Officials from Public Health England (PHE) have confirmed yesterday (26th September 2018) that a third person in UK has been diagnosed with monkey pox. While the first two patients had most likely picked up the infection from Nigeria, this third infection has occurred in a healthcare worker who was treating one of the first two infected patients at Blackpool Victoria Hospital.

Johns Hopkins researchers discover oxaliplatin-based nerve damage

Oxaliplatin, a platinum-based anticancer drug that's made enormous headway in recent years against colorectal cancer, appears to cause nerve damage that may be permanent and worsens even months after treatment ends.

Read more Medical News

› Verified 1 days ago

Provider NameDebbie M Garcia
Provider TypePractitioner - Clinical Psychologist
Provider IdentifiersNPI Number: 1295090371
PECOS PAC ID: 2961624903
Enrollment ID: I20170630001117

News Archive

New Cornell discovery could lead to effective treatment for tuberculosis

A recent discovery by Cornell University researchers could lead to a new, effective treatment for persistent tuberculosis infections.

A new report on health spending by Americans

There have been several studies showing that spending on health by Americans is on the rise, and around 18 percent of the US economy is individual spending on health. A study titled, "US Health Care Spending by Payer and Health Condition, 1996-2016," was published in the latest issue of JAMA today.

Rosetta Genomics reports revenues of $150,000 for full-year 2009

Rosetta Genomics, Ltd., a leading developer of microRNA-based molecular diagnostics, today reported that on March 26, 2010 the Company filed its Form 20-F with the U.S. Securities and Exchange Committee, which contains financial results for the three and 12 months ended December 31, 2009.

Third case of monkey pox confirmed in UK

Officials from Public Health England (PHE) have confirmed yesterday (26th September 2018) that a third person in UK has been diagnosed with monkey pox. While the first two patients had most likely picked up the infection from Nigeria, this third infection has occurred in a healthcare worker who was treating one of the first two infected patients at Blackpool Victoria Hospital.

Johns Hopkins researchers discover oxaliplatin-based nerve damage

Oxaliplatin, a platinum-based anticancer drug that's made enormous headway in recent years against colorectal cancer, appears to cause nerve damage that may be permanent and worsens even months after treatment ends.

Read more Medical News

› Verified 1 days ago

Provider NameLori Coplen
Provider TypePractitioner - Clinical Social Worker
Provider IdentifiersNPI Number: 1588194757
PECOS PAC ID: 8325318348
Enrollment ID: I20170725001696

News Archive

New Cornell discovery could lead to effective treatment for tuberculosis

A recent discovery by Cornell University researchers could lead to a new, effective treatment for persistent tuberculosis infections.

A new report on health spending by Americans

There have been several studies showing that spending on health by Americans is on the rise, and around 18 percent of the US economy is individual spending on health. A study titled, "US Health Care Spending by Payer and Health Condition, 1996-2016," was published in the latest issue of JAMA today.

Rosetta Genomics reports revenues of $150,000 for full-year 2009

Rosetta Genomics, Ltd., a leading developer of microRNA-based molecular diagnostics, today reported that on March 26, 2010 the Company filed its Form 20-F with the U.S. Securities and Exchange Committee, which contains financial results for the three and 12 months ended December 31, 2009.

Third case of monkey pox confirmed in UK

Officials from Public Health England (PHE) have confirmed yesterday (26th September 2018) that a third person in UK has been diagnosed with monkey pox. While the first two patients had most likely picked up the infection from Nigeria, this third infection has occurred in a healthcare worker who was treating one of the first two infected patients at Blackpool Victoria Hospital.

Johns Hopkins researchers discover oxaliplatin-based nerve damage

Oxaliplatin, a platinum-based anticancer drug that's made enormous headway in recent years against colorectal cancer, appears to cause nerve damage that may be permanent and worsens even months after treatment ends.

Read more Medical News

› Verified 1 days ago

Provider NameJazmin Veronik Graham
Provider TypePractitioner - Clinical Social Worker
Provider IdentifiersNPI Number: 1407243694
PECOS PAC ID: 4880968668
Enrollment ID: I20170918000962

News Archive

New Cornell discovery could lead to effective treatment for tuberculosis

A recent discovery by Cornell University researchers could lead to a new, effective treatment for persistent tuberculosis infections.

A new report on health spending by Americans

There have been several studies showing that spending on health by Americans is on the rise, and around 18 percent of the US economy is individual spending on health. A study titled, "US Health Care Spending by Payer and Health Condition, 1996-2016," was published in the latest issue of JAMA today.

Rosetta Genomics reports revenues of $150,000 for full-year 2009

Rosetta Genomics, Ltd., a leading developer of microRNA-based molecular diagnostics, today reported that on March 26, 2010 the Company filed its Form 20-F with the U.S. Securities and Exchange Committee, which contains financial results for the three and 12 months ended December 31, 2009.

Third case of monkey pox confirmed in UK

Officials from Public Health England (PHE) have confirmed yesterday (26th September 2018) that a third person in UK has been diagnosed with monkey pox. While the first two patients had most likely picked up the infection from Nigeria, this third infection has occurred in a healthcare worker who was treating one of the first two infected patients at Blackpool Victoria Hospital.

Johns Hopkins researchers discover oxaliplatin-based nerve damage

Oxaliplatin, a platinum-based anticancer drug that's made enormous headway in recent years against colorectal cancer, appears to cause nerve damage that may be permanent and worsens even months after treatment ends.

Read more Medical News

› Verified 1 days ago

Provider NameAndrea Urbanek
Provider TypePractitioner - Clinical Social Worker
Provider IdentifiersNPI Number: 1245761113
PECOS PAC ID: 9234405812
Enrollment ID: I20171026001064

News Archive

New Cornell discovery could lead to effective treatment for tuberculosis

A recent discovery by Cornell University researchers could lead to a new, effective treatment for persistent tuberculosis infections.

A new report on health spending by Americans

There have been several studies showing that spending on health by Americans is on the rise, and around 18 percent of the US economy is individual spending on health. A study titled, "US Health Care Spending by Payer and Health Condition, 1996-2016," was published in the latest issue of JAMA today.

Rosetta Genomics reports revenues of $150,000 for full-year 2009

Rosetta Genomics, Ltd., a leading developer of microRNA-based molecular diagnostics, today reported that on March 26, 2010 the Company filed its Form 20-F with the U.S. Securities and Exchange Committee, which contains financial results for the three and 12 months ended December 31, 2009.

Third case of monkey pox confirmed in UK

Officials from Public Health England (PHE) have confirmed yesterday (26th September 2018) that a third person in UK has been diagnosed with monkey pox. While the first two patients had most likely picked up the infection from Nigeria, this third infection has occurred in a healthcare worker who was treating one of the first two infected patients at Blackpool Victoria Hospital.

Johns Hopkins researchers discover oxaliplatin-based nerve damage

Oxaliplatin, a platinum-based anticancer drug that's made enormous headway in recent years against colorectal cancer, appears to cause nerve damage that may be permanent and worsens even months after treatment ends.

Read more Medical News

› Verified 1 days ago

Provider NameAnne Marie Lamendola
Provider TypePractitioner - Clinical Social Worker
Provider IdentifiersNPI Number: 1942728670
PECOS PAC ID: 0648536730
Enrollment ID: I20171106001550

News Archive

New Cornell discovery could lead to effective treatment for tuberculosis

A recent discovery by Cornell University researchers could lead to a new, effective treatment for persistent tuberculosis infections.

A new report on health spending by Americans

There have been several studies showing that spending on health by Americans is on the rise, and around 18 percent of the US economy is individual spending on health. A study titled, "US Health Care Spending by Payer and Health Condition, 1996-2016," was published in the latest issue of JAMA today.

Rosetta Genomics reports revenues of $150,000 for full-year 2009

Rosetta Genomics, Ltd., a leading developer of microRNA-based molecular diagnostics, today reported that on March 26, 2010 the Company filed its Form 20-F with the U.S. Securities and Exchange Committee, which contains financial results for the three and 12 months ended December 31, 2009.

Third case of monkey pox confirmed in UK

Officials from Public Health England (PHE) have confirmed yesterday (26th September 2018) that a third person in UK has been diagnosed with monkey pox. While the first two patients had most likely picked up the infection from Nigeria, this third infection has occurred in a healthcare worker who was treating one of the first two infected patients at Blackpool Victoria Hospital.

Johns Hopkins researchers discover oxaliplatin-based nerve damage

Oxaliplatin, a platinum-based anticancer drug that's made enormous headway in recent years against colorectal cancer, appears to cause nerve damage that may be permanent and worsens even months after treatment ends.

Read more Medical News

› Verified 1 days ago

Provider NameJennifer Lynn Foreman
Provider TypePractitioner - Clinical Social Worker
Provider IdentifiersNPI Number: 1548760986
PECOS PAC ID: 9032470695
Enrollment ID: I20180223000885

News Archive

New Cornell discovery could lead to effective treatment for tuberculosis

A recent discovery by Cornell University researchers could lead to a new, effective treatment for persistent tuberculosis infections.

A new report on health spending by Americans

There have been several studies showing that spending on health by Americans is on the rise, and around 18 percent of the US economy is individual spending on health. A study titled, "US Health Care Spending by Payer and Health Condition, 1996-2016," was published in the latest issue of JAMA today.

Rosetta Genomics reports revenues of $150,000 for full-year 2009

Rosetta Genomics, Ltd., a leading developer of microRNA-based molecular diagnostics, today reported that on March 26, 2010 the Company filed its Form 20-F with the U.S. Securities and Exchange Committee, which contains financial results for the three and 12 months ended December 31, 2009.

Third case of monkey pox confirmed in UK

Officials from Public Health England (PHE) have confirmed yesterday (26th September 2018) that a third person in UK has been diagnosed with monkey pox. While the first two patients had most likely picked up the infection from Nigeria, this third infection has occurred in a healthcare worker who was treating one of the first two infected patients at Blackpool Victoria Hospital.

Johns Hopkins researchers discover oxaliplatin-based nerve damage

Oxaliplatin, a platinum-based anticancer drug that's made enormous headway in recent years against colorectal cancer, appears to cause nerve damage that may be permanent and worsens even months after treatment ends.

Read more Medical News

› Verified 1 days ago

Provider NameLynn Mcpherson Cearley
Provider TypePractitioner - Clinical Social Worker
Provider IdentifiersNPI Number: 1679533095
PECOS PAC ID: 3971867508
Enrollment ID: I20180508001556

News Archive

New Cornell discovery could lead to effective treatment for tuberculosis

A recent discovery by Cornell University researchers could lead to a new, effective treatment for persistent tuberculosis infections.

A new report on health spending by Americans

There have been several studies showing that spending on health by Americans is on the rise, and around 18 percent of the US economy is individual spending on health. A study titled, "US Health Care Spending by Payer and Health Condition, 1996-2016," was published in the latest issue of JAMA today.

Rosetta Genomics reports revenues of $150,000 for full-year 2009

Rosetta Genomics, Ltd., a leading developer of microRNA-based molecular diagnostics, today reported that on March 26, 2010 the Company filed its Form 20-F with the U.S. Securities and Exchange Committee, which contains financial results for the three and 12 months ended December 31, 2009.

Third case of monkey pox confirmed in UK

Officials from Public Health England (PHE) have confirmed yesterday (26th September 2018) that a third person in UK has been diagnosed with monkey pox. While the first two patients had most likely picked up the infection from Nigeria, this third infection has occurred in a healthcare worker who was treating one of the first two infected patients at Blackpool Victoria Hospital.

Johns Hopkins researchers discover oxaliplatin-based nerve damage

Oxaliplatin, a platinum-based anticancer drug that's made enormous headway in recent years against colorectal cancer, appears to cause nerve damage that may be permanent and worsens even months after treatment ends.

Read more Medical News

› Verified 1 days ago

Provider NameArun Joshua Mathew
Provider TypePractitioner - Clinical Social Worker
Provider IdentifiersNPI Number: 1821265133
PECOS PAC ID: 2860662558
Enrollment ID: I20180509002897

News Archive

New Cornell discovery could lead to effective treatment for tuberculosis

A recent discovery by Cornell University researchers could lead to a new, effective treatment for persistent tuberculosis infections.

A new report on health spending by Americans

There have been several studies showing that spending on health by Americans is on the rise, and around 18 percent of the US economy is individual spending on health. A study titled, "US Health Care Spending by Payer and Health Condition, 1996-2016," was published in the latest issue of JAMA today.

Rosetta Genomics reports revenues of $150,000 for full-year 2009

Rosetta Genomics, Ltd., a leading developer of microRNA-based molecular diagnostics, today reported that on March 26, 2010 the Company filed its Form 20-F with the U.S. Securities and Exchange Committee, which contains financial results for the three and 12 months ended December 31, 2009.

Third case of monkey pox confirmed in UK

Officials from Public Health England (PHE) have confirmed yesterday (26th September 2018) that a third person in UK has been diagnosed with monkey pox. While the first two patients had most likely picked up the infection from Nigeria, this third infection has occurred in a healthcare worker who was treating one of the first two infected patients at Blackpool Victoria Hospital.

Johns Hopkins researchers discover oxaliplatin-based nerve damage

Oxaliplatin, a platinum-based anticancer drug that's made enormous headway in recent years against colorectal cancer, appears to cause nerve damage that may be permanent and worsens even months after treatment ends.

Read more Medical News

› Verified 1 days ago

Provider NameKenethia Louise Morgan
Provider TypePractitioner - Clinical Social Worker
Provider IdentifiersNPI Number: 1699112979
PECOS PAC ID: 6507100377
Enrollment ID: I20181205001070

News Archive

New Cornell discovery could lead to effective treatment for tuberculosis

A recent discovery by Cornell University researchers could lead to a new, effective treatment for persistent tuberculosis infections.

A new report on health spending by Americans

There have been several studies showing that spending on health by Americans is on the rise, and around 18 percent of the US economy is individual spending on health. A study titled, "US Health Care Spending by Payer and Health Condition, 1996-2016," was published in the latest issue of JAMA today.

Rosetta Genomics reports revenues of $150,000 for full-year 2009

Rosetta Genomics, Ltd., a leading developer of microRNA-based molecular diagnostics, today reported that on March 26, 2010 the Company filed its Form 20-F with the U.S. Securities and Exchange Committee, which contains financial results for the three and 12 months ended December 31, 2009.

Third case of monkey pox confirmed in UK

Officials from Public Health England (PHE) have confirmed yesterday (26th September 2018) that a third person in UK has been diagnosed with monkey pox. While the first two patients had most likely picked up the infection from Nigeria, this third infection has occurred in a healthcare worker who was treating one of the first two infected patients at Blackpool Victoria Hospital.

Johns Hopkins researchers discover oxaliplatin-based nerve damage

Oxaliplatin, a platinum-based anticancer drug that's made enormous headway in recent years against colorectal cancer, appears to cause nerve damage that may be permanent and worsens even months after treatment ends.

Read more Medical News

› Verified 1 days ago

Provider NameJaleesa Dunn
Provider TypePractitioner - Clinical Social Worker
Provider IdentifiersNPI Number: 1538561741
PECOS PAC ID: 0547501421
Enrollment ID: I20190402001182

News Archive

New Cornell discovery could lead to effective treatment for tuberculosis

A recent discovery by Cornell University researchers could lead to a new, effective treatment for persistent tuberculosis infections.

A new report on health spending by Americans

There have been several studies showing that spending on health by Americans is on the rise, and around 18 percent of the US economy is individual spending on health. A study titled, "US Health Care Spending by Payer and Health Condition, 1996-2016," was published in the latest issue of JAMA today.

Rosetta Genomics reports revenues of $150,000 for full-year 2009

Rosetta Genomics, Ltd., a leading developer of microRNA-based molecular diagnostics, today reported that on March 26, 2010 the Company filed its Form 20-F with the U.S. Securities and Exchange Committee, which contains financial results for the three and 12 months ended December 31, 2009.

Third case of monkey pox confirmed in UK

Officials from Public Health England (PHE) have confirmed yesterday (26th September 2018) that a third person in UK has been diagnosed with monkey pox. While the first two patients had most likely picked up the infection from Nigeria, this third infection has occurred in a healthcare worker who was treating one of the first two infected patients at Blackpool Victoria Hospital.

Johns Hopkins researchers discover oxaliplatin-based nerve damage

Oxaliplatin, a platinum-based anticancer drug that's made enormous headway in recent years against colorectal cancer, appears to cause nerve damage that may be permanent and worsens even months after treatment ends.

Read more Medical News

› Verified 1 days ago

Provider NameLori Russell-siemer
Provider TypePractitioner - Clinical Social Worker
Provider IdentifiersNPI Number: 1609349489
PECOS PAC ID: 8325371156
Enrollment ID: I20190611002048

News Archive

New Cornell discovery could lead to effective treatment for tuberculosis

A recent discovery by Cornell University researchers could lead to a new, effective treatment for persistent tuberculosis infections.

A new report on health spending by Americans

There have been several studies showing that spending on health by Americans is on the rise, and around 18 percent of the US economy is individual spending on health. A study titled, "US Health Care Spending by Payer and Health Condition, 1996-2016," was published in the latest issue of JAMA today.

Rosetta Genomics reports revenues of $150,000 for full-year 2009

Rosetta Genomics, Ltd., a leading developer of microRNA-based molecular diagnostics, today reported that on March 26, 2010 the Company filed its Form 20-F with the U.S. Securities and Exchange Committee, which contains financial results for the three and 12 months ended December 31, 2009.

Third case of monkey pox confirmed in UK

Officials from Public Health England (PHE) have confirmed yesterday (26th September 2018) that a third person in UK has been diagnosed with monkey pox. While the first two patients had most likely picked up the infection from Nigeria, this third infection has occurred in a healthcare worker who was treating one of the first two infected patients at Blackpool Victoria Hospital.

Johns Hopkins researchers discover oxaliplatin-based nerve damage

Oxaliplatin, a platinum-based anticancer drug that's made enormous headway in recent years against colorectal cancer, appears to cause nerve damage that may be permanent and worsens even months after treatment ends.

Read more Medical News

› Verified 1 days ago

Provider NameLora Hamilton
Provider TypePractitioner - Clinical Social Worker
Provider IdentifiersNPI Number: 1073076865
PECOS PAC ID: 7618202334
Enrollment ID: I20190717001047

News Archive

New Cornell discovery could lead to effective treatment for tuberculosis

A recent discovery by Cornell University researchers could lead to a new, effective treatment for persistent tuberculosis infections.

A new report on health spending by Americans

There have been several studies showing that spending on health by Americans is on the rise, and around 18 percent of the US economy is individual spending on health. A study titled, "US Health Care Spending by Payer and Health Condition, 1996-2016," was published in the latest issue of JAMA today.

Rosetta Genomics reports revenues of $150,000 for full-year 2009

Rosetta Genomics, Ltd., a leading developer of microRNA-based molecular diagnostics, today reported that on March 26, 2010 the Company filed its Form 20-F with the U.S. Securities and Exchange Committee, which contains financial results for the three and 12 months ended December 31, 2009.

Third case of monkey pox confirmed in UK

Officials from Public Health England (PHE) have confirmed yesterday (26th September 2018) that a third person in UK has been diagnosed with monkey pox. While the first two patients had most likely picked up the infection from Nigeria, this third infection has occurred in a healthcare worker who was treating one of the first two infected patients at Blackpool Victoria Hospital.

Johns Hopkins researchers discover oxaliplatin-based nerve damage

Oxaliplatin, a platinum-based anticancer drug that's made enormous headway in recent years against colorectal cancer, appears to cause nerve damage that may be permanent and worsens even months after treatment ends.

Read more Medical News

› Verified 1 days ago

Provider NameSonja Guillory
Provider TypePractitioner - Clinical Social Worker
Provider IdentifiersNPI Number: 1376107730
PECOS PAC ID: 8123355682
Enrollment ID: I20190807001774

News Archive

New Cornell discovery could lead to effective treatment for tuberculosis

A recent discovery by Cornell University researchers could lead to a new, effective treatment for persistent tuberculosis infections.

A new report on health spending by Americans

There have been several studies showing that spending on health by Americans is on the rise, and around 18 percent of the US economy is individual spending on health. A study titled, "US Health Care Spending by Payer and Health Condition, 1996-2016," was published in the latest issue of JAMA today.

Rosetta Genomics reports revenues of $150,000 for full-year 2009

Rosetta Genomics, Ltd., a leading developer of microRNA-based molecular diagnostics, today reported that on March 26, 2010 the Company filed its Form 20-F with the U.S. Securities and Exchange Committee, which contains financial results for the three and 12 months ended December 31, 2009.

Third case of monkey pox confirmed in UK

Officials from Public Health England (PHE) have confirmed yesterday (26th September 2018) that a third person in UK has been diagnosed with monkey pox. While the first two patients had most likely picked up the infection from Nigeria, this third infection has occurred in a healthcare worker who was treating one of the first two infected patients at Blackpool Victoria Hospital.

Johns Hopkins researchers discover oxaliplatin-based nerve damage

Oxaliplatin, a platinum-based anticancer drug that's made enormous headway in recent years against colorectal cancer, appears to cause nerve damage that may be permanent and worsens even months after treatment ends.

Read more Medical News

› Verified 1 days ago

Provider NameGregory Dawson
Provider TypePractitioner - Clinical Social Worker
Provider IdentifiersNPI Number: 1619355740
PECOS PAC ID: 7911235965
Enrollment ID: I20190828003671

News Archive

New Cornell discovery could lead to effective treatment for tuberculosis

A recent discovery by Cornell University researchers could lead to a new, effective treatment for persistent tuberculosis infections.

A new report on health spending by Americans

There have been several studies showing that spending on health by Americans is on the rise, and around 18 percent of the US economy is individual spending on health. A study titled, "US Health Care Spending by Payer and Health Condition, 1996-2016," was published in the latest issue of JAMA today.

Rosetta Genomics reports revenues of $150,000 for full-year 2009

Rosetta Genomics, Ltd., a leading developer of microRNA-based molecular diagnostics, today reported that on March 26, 2010 the Company filed its Form 20-F with the U.S. Securities and Exchange Committee, which contains financial results for the three and 12 months ended December 31, 2009.

Third case of monkey pox confirmed in UK

Officials from Public Health England (PHE) have confirmed yesterday (26th September 2018) that a third person in UK has been diagnosed with monkey pox. While the first two patients had most likely picked up the infection from Nigeria, this third infection has occurred in a healthcare worker who was treating one of the first two infected patients at Blackpool Victoria Hospital.

Johns Hopkins researchers discover oxaliplatin-based nerve damage

Oxaliplatin, a platinum-based anticancer drug that's made enormous headway in recent years against colorectal cancer, appears to cause nerve damage that may be permanent and worsens even months after treatment ends.

Read more Medical News

› Verified 1 days ago

Provider NameAriana Danielle Mczeal
Provider TypePractitioner - Clinical Social Worker
Provider IdentifiersNPI Number: 1811558711
PECOS PAC ID: 0749510139
Enrollment ID: I20190927001180

News Archive

New Cornell discovery could lead to effective treatment for tuberculosis

A recent discovery by Cornell University researchers could lead to a new, effective treatment for persistent tuberculosis infections.

A new report on health spending by Americans

There have been several studies showing that spending on health by Americans is on the rise, and around 18 percent of the US economy is individual spending on health. A study titled, "US Health Care Spending by Payer and Health Condition, 1996-2016," was published in the latest issue of JAMA today.

Rosetta Genomics reports revenues of $150,000 for full-year 2009

Rosetta Genomics, Ltd., a leading developer of microRNA-based molecular diagnostics, today reported that on March 26, 2010 the Company filed its Form 20-F with the U.S. Securities and Exchange Committee, which contains financial results for the three and 12 months ended December 31, 2009.

Third case of monkey pox confirmed in UK

Officials from Public Health England (PHE) have confirmed yesterday (26th September 2018) that a third person in UK has been diagnosed with monkey pox. While the first two patients had most likely picked up the infection from Nigeria, this third infection has occurred in a healthcare worker who was treating one of the first two infected patients at Blackpool Victoria Hospital.

Johns Hopkins researchers discover oxaliplatin-based nerve damage

Oxaliplatin, a platinum-based anticancer drug that's made enormous headway in recent years against colorectal cancer, appears to cause nerve damage that may be permanent and worsens even months after treatment ends.

Read more Medical News

› Verified 1 days ago

Provider NameBryan S Phillips
Provider TypePractitioner - Clinical Social Worker
Provider IdentifiersNPI Number: 1962459255
PECOS PAC ID: 8527399880
Enrollment ID: I20191017001479

News Archive

New Cornell discovery could lead to effective treatment for tuberculosis

A recent discovery by Cornell University researchers could lead to a new, effective treatment for persistent tuberculosis infections.

A new report on health spending by Americans

There have been several studies showing that spending on health by Americans is on the rise, and around 18 percent of the US economy is individual spending on health. A study titled, "US Health Care Spending by Payer and Health Condition, 1996-2016," was published in the latest issue of JAMA today.

Rosetta Genomics reports revenues of $150,000 for full-year 2009

Rosetta Genomics, Ltd., a leading developer of microRNA-based molecular diagnostics, today reported that on March 26, 2010 the Company filed its Form 20-F with the U.S. Securities and Exchange Committee, which contains financial results for the three and 12 months ended December 31, 2009.

Third case of monkey pox confirmed in UK

Officials from Public Health England (PHE) have confirmed yesterday (26th September 2018) that a third person in UK has been diagnosed with monkey pox. While the first two patients had most likely picked up the infection from Nigeria, this third infection has occurred in a healthcare worker who was treating one of the first two infected patients at Blackpool Victoria Hospital.

Johns Hopkins researchers discover oxaliplatin-based nerve damage

Oxaliplatin, a platinum-based anticancer drug that's made enormous headway in recent years against colorectal cancer, appears to cause nerve damage that may be permanent and worsens even months after treatment ends.

Read more Medical News

› Verified 1 days ago

Provider NameRuby Johnson
Provider TypePractitioner - Clinical Social Worker
Provider IdentifiersNPI Number: 1710334396
PECOS PAC ID: 5799017414
Enrollment ID: I20191030001835

News Archive

New Cornell discovery could lead to effective treatment for tuberculosis

A recent discovery by Cornell University researchers could lead to a new, effective treatment for persistent tuberculosis infections.

A new report on health spending by Americans

There have been several studies showing that spending on health by Americans is on the rise, and around 18 percent of the US economy is individual spending on health. A study titled, "US Health Care Spending by Payer and Health Condition, 1996-2016," was published in the latest issue of JAMA today.

Rosetta Genomics reports revenues of $150,000 for full-year 2009

Rosetta Genomics, Ltd., a leading developer of microRNA-based molecular diagnostics, today reported that on March 26, 2010 the Company filed its Form 20-F with the U.S. Securities and Exchange Committee, which contains financial results for the three and 12 months ended December 31, 2009.

Third case of monkey pox confirmed in UK

Officials from Public Health England (PHE) have confirmed yesterday (26th September 2018) that a third person in UK has been diagnosed with monkey pox. While the first two patients had most likely picked up the infection from Nigeria, this third infection has occurred in a healthcare worker who was treating one of the first two infected patients at Blackpool Victoria Hospital.

Johns Hopkins researchers discover oxaliplatin-based nerve damage

Oxaliplatin, a platinum-based anticancer drug that's made enormous headway in recent years against colorectal cancer, appears to cause nerve damage that may be permanent and worsens even months after treatment ends.

Read more Medical News

› Verified 1 days ago

Provider NameEsmeralda Essie Nigo
Provider TypePractitioner - Clinical Social Worker
Provider IdentifiersNPI Number: 1649821562
PECOS PAC ID: 6002148731
Enrollment ID: I20191030002519

News Archive

New Cornell discovery could lead to effective treatment for tuberculosis

A recent discovery by Cornell University researchers could lead to a new, effective treatment for persistent tuberculosis infections.

A new report on health spending by Americans

There have been several studies showing that spending on health by Americans is on the rise, and around 18 percent of the US economy is individual spending on health. A study titled, "US Health Care Spending by Payer and Health Condition, 1996-2016," was published in the latest issue of JAMA today.

Rosetta Genomics reports revenues of $150,000 for full-year 2009

Rosetta Genomics, Ltd., a leading developer of microRNA-based molecular diagnostics, today reported that on March 26, 2010 the Company filed its Form 20-F with the U.S. Securities and Exchange Committee, which contains financial results for the three and 12 months ended December 31, 2009.

Third case of monkey pox confirmed in UK

Officials from Public Health England (PHE) have confirmed yesterday (26th September 2018) that a third person in UK has been diagnosed with monkey pox. While the first two patients had most likely picked up the infection from Nigeria, this third infection has occurred in a healthcare worker who was treating one of the first two infected patients at Blackpool Victoria Hospital.

Johns Hopkins researchers discover oxaliplatin-based nerve damage

Oxaliplatin, a platinum-based anticancer drug that's made enormous headway in recent years against colorectal cancer, appears to cause nerve damage that may be permanent and worsens even months after treatment ends.

Read more Medical News

› Verified 1 days ago

Provider NameDonald Ray Mahan
Provider TypePractitioner - Clinical Social Worker
Provider IdentifiersNPI Number: 1154749257
PECOS PAC ID: 2567898745
Enrollment ID: I20200206001567

News Archive

New Cornell discovery could lead to effective treatment for tuberculosis

A recent discovery by Cornell University researchers could lead to a new, effective treatment for persistent tuberculosis infections.

A new report on health spending by Americans

There have been several studies showing that spending on health by Americans is on the rise, and around 18 percent of the US economy is individual spending on health. A study titled, "US Health Care Spending by Payer and Health Condition, 1996-2016," was published in the latest issue of JAMA today.

Rosetta Genomics reports revenues of $150,000 for full-year 2009

Rosetta Genomics, Ltd., a leading developer of microRNA-based molecular diagnostics, today reported that on March 26, 2010 the Company filed its Form 20-F with the U.S. Securities and Exchange Committee, which contains financial results for the three and 12 months ended December 31, 2009.

Third case of monkey pox confirmed in UK

Officials from Public Health England (PHE) have confirmed yesterday (26th September 2018) that a third person in UK has been diagnosed with monkey pox. While the first two patients had most likely picked up the infection from Nigeria, this third infection has occurred in a healthcare worker who was treating one of the first two infected patients at Blackpool Victoria Hospital.

Johns Hopkins researchers discover oxaliplatin-based nerve damage

Oxaliplatin, a platinum-based anticancer drug that's made enormous headway in recent years against colorectal cancer, appears to cause nerve damage that may be permanent and worsens even months after treatment ends.

Read more Medical News

› Verified 1 days ago

Provider NameMachanta Newson
Provider TypePractitioner - Clinical Social Worker
Provider IdentifiersNPI Number: 1902949688
PECOS PAC ID: 4284887969
Enrollment ID: I20200528002446

News Archive

New Cornell discovery could lead to effective treatment for tuberculosis

A recent discovery by Cornell University researchers could lead to a new, effective treatment for persistent tuberculosis infections.

A new report on health spending by Americans

There have been several studies showing that spending on health by Americans is on the rise, and around 18 percent of the US economy is individual spending on health. A study titled, "US Health Care Spending by Payer and Health Condition, 1996-2016," was published in the latest issue of JAMA today.

Rosetta Genomics reports revenues of $150,000 for full-year 2009

Rosetta Genomics, Ltd., a leading developer of microRNA-based molecular diagnostics, today reported that on March 26, 2010 the Company filed its Form 20-F with the U.S. Securities and Exchange Committee, which contains financial results for the three and 12 months ended December 31, 2009.

Third case of monkey pox confirmed in UK

Officials from Public Health England (PHE) have confirmed yesterday (26th September 2018) that a third person in UK has been diagnosed with monkey pox. While the first two patients had most likely picked up the infection from Nigeria, this third infection has occurred in a healthcare worker who was treating one of the first two infected patients at Blackpool Victoria Hospital.

Johns Hopkins researchers discover oxaliplatin-based nerve damage

Oxaliplatin, a platinum-based anticancer drug that's made enormous headway in recent years against colorectal cancer, appears to cause nerve damage that may be permanent and worsens even months after treatment ends.

Read more Medical News

› Verified 1 days ago

Provider NameKeren- Happuch Lynne Simmons
Provider TypePractitioner - Clinical Social Worker
Provider IdentifiersNPI Number: 1285250696
PECOS PAC ID: 4981026689
Enrollment ID: I20200625003188

News Archive

New Cornell discovery could lead to effective treatment for tuberculosis

A recent discovery by Cornell University researchers could lead to a new, effective treatment for persistent tuberculosis infections.

A new report on health spending by Americans

There have been several studies showing that spending on health by Americans is on the rise, and around 18 percent of the US economy is individual spending on health. A study titled, "US Health Care Spending by Payer and Health Condition, 1996-2016," was published in the latest issue of JAMA today.

Rosetta Genomics reports revenues of $150,000 for full-year 2009

Rosetta Genomics, Ltd., a leading developer of microRNA-based molecular diagnostics, today reported that on March 26, 2010 the Company filed its Form 20-F with the U.S. Securities and Exchange Committee, which contains financial results for the three and 12 months ended December 31, 2009.

Third case of monkey pox confirmed in UK

Officials from Public Health England (PHE) have confirmed yesterday (26th September 2018) that a third person in UK has been diagnosed with monkey pox. While the first two patients had most likely picked up the infection from Nigeria, this third infection has occurred in a healthcare worker who was treating one of the first two infected patients at Blackpool Victoria Hospital.

Johns Hopkins researchers discover oxaliplatin-based nerve damage

Oxaliplatin, a platinum-based anticancer drug that's made enormous headway in recent years against colorectal cancer, appears to cause nerve damage that may be permanent and worsens even months after treatment ends.

Read more Medical News

› Verified 1 days ago

Provider NameHolly Horton Randall
Provider TypePractitioner - Clinical Social Worker
Provider IdentifiersNPI Number: 1649518028
PECOS PAC ID: 9638595457
Enrollment ID: I20200811002525

News Archive

New Cornell discovery could lead to effective treatment for tuberculosis

A recent discovery by Cornell University researchers could lead to a new, effective treatment for persistent tuberculosis infections.

A new report on health spending by Americans

There have been several studies showing that spending on health by Americans is on the rise, and around 18 percent of the US economy is individual spending on health. A study titled, "US Health Care Spending by Payer and Health Condition, 1996-2016," was published in the latest issue of JAMA today.

Rosetta Genomics reports revenues of $150,000 for full-year 2009

Rosetta Genomics, Ltd., a leading developer of microRNA-based molecular diagnostics, today reported that on March 26, 2010 the Company filed its Form 20-F with the U.S. Securities and Exchange Committee, which contains financial results for the three and 12 months ended December 31, 2009.

Third case of monkey pox confirmed in UK

Officials from Public Health England (PHE) have confirmed yesterday (26th September 2018) that a third person in UK has been diagnosed with monkey pox. While the first two patients had most likely picked up the infection from Nigeria, this third infection has occurred in a healthcare worker who was treating one of the first two infected patients at Blackpool Victoria Hospital.

Johns Hopkins researchers discover oxaliplatin-based nerve damage

Oxaliplatin, a platinum-based anticancer drug that's made enormous headway in recent years against colorectal cancer, appears to cause nerve damage that may be permanent and worsens even months after treatment ends.

Read more Medical News

› Verified 1 days ago

Provider NameSheila Michelle Hatfield
Provider TypePractitioner - Clinical Social Worker
Provider IdentifiersNPI Number: 1255957601
PECOS PAC ID: 1254758071
Enrollment ID: I20200825002497

News Archive

New Cornell discovery could lead to effective treatment for tuberculosis

A recent discovery by Cornell University researchers could lead to a new, effective treatment for persistent tuberculosis infections.

A new report on health spending by Americans

There have been several studies showing that spending on health by Americans is on the rise, and around 18 percent of the US economy is individual spending on health. A study titled, "US Health Care Spending by Payer and Health Condition, 1996-2016," was published in the latest issue of JAMA today.

Rosetta Genomics reports revenues of $150,000 for full-year 2009

Rosetta Genomics, Ltd., a leading developer of microRNA-based molecular diagnostics, today reported that on March 26, 2010 the Company filed its Form 20-F with the U.S. Securities and Exchange Committee, which contains financial results for the three and 12 months ended December 31, 2009.

Third case of monkey pox confirmed in UK

Officials from Public Health England (PHE) have confirmed yesterday (26th September 2018) that a third person in UK has been diagnosed with monkey pox. While the first two patients had most likely picked up the infection from Nigeria, this third infection has occurred in a healthcare worker who was treating one of the first two infected patients at Blackpool Victoria Hospital.

Johns Hopkins researchers discover oxaliplatin-based nerve damage

Oxaliplatin, a platinum-based anticancer drug that's made enormous headway in recent years against colorectal cancer, appears to cause nerve damage that may be permanent and worsens even months after treatment ends.

Read more Medical News

› Verified 1 days ago

Provider NameAlayne Billingsley
Provider TypePractitioner - Clinical Social Worker
Provider IdentifiersNPI Number: 1700442217
PECOS PAC ID: 2961817572
Enrollment ID: I20210212000220

News Archive

New Cornell discovery could lead to effective treatment for tuberculosis

A recent discovery by Cornell University researchers could lead to a new, effective treatment for persistent tuberculosis infections.

A new report on health spending by Americans

There have been several studies showing that spending on health by Americans is on the rise, and around 18 percent of the US economy is individual spending on health. A study titled, "US Health Care Spending by Payer and Health Condition, 1996-2016," was published in the latest issue of JAMA today.

Rosetta Genomics reports revenues of $150,000 for full-year 2009

Rosetta Genomics, Ltd., a leading developer of microRNA-based molecular diagnostics, today reported that on March 26, 2010 the Company filed its Form 20-F with the U.S. Securities and Exchange Committee, which contains financial results for the three and 12 months ended December 31, 2009.

Third case of monkey pox confirmed in UK

Officials from Public Health England (PHE) have confirmed yesterday (26th September 2018) that a third person in UK has been diagnosed with monkey pox. While the first two patients had most likely picked up the infection from Nigeria, this third infection has occurred in a healthcare worker who was treating one of the first two infected patients at Blackpool Victoria Hospital.

Johns Hopkins researchers discover oxaliplatin-based nerve damage

Oxaliplatin, a platinum-based anticancer drug that's made enormous headway in recent years against colorectal cancer, appears to cause nerve damage that may be permanent and worsens even months after treatment ends.

Read more Medical News

› Verified 1 days ago

Provider NameJennifer Jean Barry
Provider TypePractitioner - Clinical Social Worker
Provider IdentifiersNPI Number: 1366048415
PECOS PAC ID: 8921413402
Enrollment ID: I20210215001727

News Archive

New Cornell discovery could lead to effective treatment for tuberculosis

A recent discovery by Cornell University researchers could lead to a new, effective treatment for persistent tuberculosis infections.

A new report on health spending by Americans

There have been several studies showing that spending on health by Americans is on the rise, and around 18 percent of the US economy is individual spending on health. A study titled, "US Health Care Spending by Payer and Health Condition, 1996-2016," was published in the latest issue of JAMA today.

Rosetta Genomics reports revenues of $150,000 for full-year 2009

Rosetta Genomics, Ltd., a leading developer of microRNA-based molecular diagnostics, today reported that on March 26, 2010 the Company filed its Form 20-F with the U.S. Securities and Exchange Committee, which contains financial results for the three and 12 months ended December 31, 2009.

Third case of monkey pox confirmed in UK

Officials from Public Health England (PHE) have confirmed yesterday (26th September 2018) that a third person in UK has been diagnosed with monkey pox. While the first two patients had most likely picked up the infection from Nigeria, this third infection has occurred in a healthcare worker who was treating one of the first two infected patients at Blackpool Victoria Hospital.

Johns Hopkins researchers discover oxaliplatin-based nerve damage

Oxaliplatin, a platinum-based anticancer drug that's made enormous headway in recent years against colorectal cancer, appears to cause nerve damage that may be permanent and worsens even months after treatment ends.

Read more Medical News

› Verified 1 days ago

Provider NameTeresa Antoinette Fuller
Provider TypePractitioner - Clinical Social Worker
Provider IdentifiersNPI Number: 1346846151
PECOS PAC ID: 1456766963
Enrollment ID: I20210216000625

News Archive

New Cornell discovery could lead to effective treatment for tuberculosis

A recent discovery by Cornell University researchers could lead to a new, effective treatment for persistent tuberculosis infections.

A new report on health spending by Americans

There have been several studies showing that spending on health by Americans is on the rise, and around 18 percent of the US economy is individual spending on health. A study titled, "US Health Care Spending by Payer and Health Condition, 1996-2016," was published in the latest issue of JAMA today.

Rosetta Genomics reports revenues of $150,000 for full-year 2009

Rosetta Genomics, Ltd., a leading developer of microRNA-based molecular diagnostics, today reported that on March 26, 2010 the Company filed its Form 20-F with the U.S. Securities and Exchange Committee, which contains financial results for the three and 12 months ended December 31, 2009.

Third case of monkey pox confirmed in UK

Officials from Public Health England (PHE) have confirmed yesterday (26th September 2018) that a third person in UK has been diagnosed with monkey pox. While the first two patients had most likely picked up the infection from Nigeria, this third infection has occurred in a healthcare worker who was treating one of the first two infected patients at Blackpool Victoria Hospital.

Johns Hopkins researchers discover oxaliplatin-based nerve damage

Oxaliplatin, a platinum-based anticancer drug that's made enormous headway in recent years against colorectal cancer, appears to cause nerve damage that may be permanent and worsens even months after treatment ends.

Read more Medical News

› Verified 1 days ago

Provider NameMarilyn Sturdivant
Provider TypePractitioner - Clinical Social Worker
Provider IdentifiersNPI Number: 1851868319
PECOS PAC ID: 2365858008
Enrollment ID: I20210304001355

News Archive

New Cornell discovery could lead to effective treatment for tuberculosis

A recent discovery by Cornell University researchers could lead to a new, effective treatment for persistent tuberculosis infections.

A new report on health spending by Americans

There have been several studies showing that spending on health by Americans is on the rise, and around 18 percent of the US economy is individual spending on health. A study titled, "US Health Care Spending by Payer and Health Condition, 1996-2016," was published in the latest issue of JAMA today.

Rosetta Genomics reports revenues of $150,000 for full-year 2009

Rosetta Genomics, Ltd., a leading developer of microRNA-based molecular diagnostics, today reported that on March 26, 2010 the Company filed its Form 20-F with the U.S. Securities and Exchange Committee, which contains financial results for the three and 12 months ended December 31, 2009.

Third case of monkey pox confirmed in UK

Officials from Public Health England (PHE) have confirmed yesterday (26th September 2018) that a third person in UK has been diagnosed with monkey pox. While the first two patients had most likely picked up the infection from Nigeria, this third infection has occurred in a healthcare worker who was treating one of the first two infected patients at Blackpool Victoria Hospital.

Johns Hopkins researchers discover oxaliplatin-based nerve damage

Oxaliplatin, a platinum-based anticancer drug that's made enormous headway in recent years against colorectal cancer, appears to cause nerve damage that may be permanent and worsens even months after treatment ends.

Read more Medical News

› Verified 1 days ago

Provider NameHannah Wadsworth
Provider TypePractitioner - Clinical Social Worker
Provider IdentifiersNPI Number: 1982245734
PECOS PAC ID: 7810303856
Enrollment ID: I20210317000385

News Archive

New Cornell discovery could lead to effective treatment for tuberculosis

A recent discovery by Cornell University researchers could lead to a new, effective treatment for persistent tuberculosis infections.

A new report on health spending by Americans

There have been several studies showing that spending on health by Americans is on the rise, and around 18 percent of the US economy is individual spending on health. A study titled, "US Health Care Spending by Payer and Health Condition, 1996-2016," was published in the latest issue of JAMA today.

Rosetta Genomics reports revenues of $150,000 for full-year 2009

Rosetta Genomics, Ltd., a leading developer of microRNA-based molecular diagnostics, today reported that on March 26, 2010 the Company filed its Form 20-F with the U.S. Securities and Exchange Committee, which contains financial results for the three and 12 months ended December 31, 2009.

Third case of monkey pox confirmed in UK

Officials from Public Health England (PHE) have confirmed yesterday (26th September 2018) that a third person in UK has been diagnosed with monkey pox. While the first two patients had most likely picked up the infection from Nigeria, this third infection has occurred in a healthcare worker who was treating one of the first two infected patients at Blackpool Victoria Hospital.

Johns Hopkins researchers discover oxaliplatin-based nerve damage

Oxaliplatin, a platinum-based anticancer drug that's made enormous headway in recent years against colorectal cancer, appears to cause nerve damage that may be permanent and worsens even months after treatment ends.

Read more Medical News

› Verified 1 days ago

Provider NameLauren Y Choi
Provider TypePractitioner - Clinical Social Worker
Provider IdentifiersNPI Number: 1902499627
PECOS PAC ID: 6103233770
Enrollment ID: I20210326000537

News Archive

New Cornell discovery could lead to effective treatment for tuberculosis

A recent discovery by Cornell University researchers could lead to a new, effective treatment for persistent tuberculosis infections.

A new report on health spending by Americans

There have been several studies showing that spending on health by Americans is on the rise, and around 18 percent of the US economy is individual spending on health. A study titled, "US Health Care Spending by Payer and Health Condition, 1996-2016," was published in the latest issue of JAMA today.

Rosetta Genomics reports revenues of $150,000 for full-year 2009

Rosetta Genomics, Ltd., a leading developer of microRNA-based molecular diagnostics, today reported that on March 26, 2010 the Company filed its Form 20-F with the U.S. Securities and Exchange Committee, which contains financial results for the three and 12 months ended December 31, 2009.

Third case of monkey pox confirmed in UK

Officials from Public Health England (PHE) have confirmed yesterday (26th September 2018) that a third person in UK has been diagnosed with monkey pox. While the first two patients had most likely picked up the infection from Nigeria, this third infection has occurred in a healthcare worker who was treating one of the first two infected patients at Blackpool Victoria Hospital.

Johns Hopkins researchers discover oxaliplatin-based nerve damage

Oxaliplatin, a platinum-based anticancer drug that's made enormous headway in recent years against colorectal cancer, appears to cause nerve damage that may be permanent and worsens even months after treatment ends.

Read more Medical News

› Verified 1 days ago

Provider NameMachaela Harrell
Provider TypePractitioner - Clinical Social Worker
Provider IdentifiersNPI Number: 1013596915
PECOS PAC ID: 6608285788
Enrollment ID: I20210430000439

News Archive

New Cornell discovery could lead to effective treatment for tuberculosis

A recent discovery by Cornell University researchers could lead to a new, effective treatment for persistent tuberculosis infections.

A new report on health spending by Americans

There have been several studies showing that spending on health by Americans is on the rise, and around 18 percent of the US economy is individual spending on health. A study titled, "US Health Care Spending by Payer and Health Condition, 1996-2016," was published in the latest issue of JAMA today.

Rosetta Genomics reports revenues of $150,000 for full-year 2009

Rosetta Genomics, Ltd., a leading developer of microRNA-based molecular diagnostics, today reported that on March 26, 2010 the Company filed its Form 20-F with the U.S. Securities and Exchange Committee, which contains financial results for the three and 12 months ended December 31, 2009.

Third case of monkey pox confirmed in UK

Officials from Public Health England (PHE) have confirmed yesterday (26th September 2018) that a third person in UK has been diagnosed with monkey pox. While the first two patients had most likely picked up the infection from Nigeria, this third infection has occurred in a healthcare worker who was treating one of the first two infected patients at Blackpool Victoria Hospital.

Johns Hopkins researchers discover oxaliplatin-based nerve damage

Oxaliplatin, a platinum-based anticancer drug that's made enormous headway in recent years against colorectal cancer, appears to cause nerve damage that may be permanent and worsens even months after treatment ends.

Read more Medical News

› Verified 1 days ago

Provider NameRosalie Cantu Flores
Provider TypePractitioner - Clinical Social Worker
Provider IdentifiersNPI Number: 1396316477
PECOS PAC ID: 4880096551
Enrollment ID: I20210719000541

News Archive

New Cornell discovery could lead to effective treatment for tuberculosis

A recent discovery by Cornell University researchers could lead to a new, effective treatment for persistent tuberculosis infections.

A new report on health spending by Americans

There have been several studies showing that spending on health by Americans is on the rise, and around 18 percent of the US economy is individual spending on health. A study titled, "US Health Care Spending by Payer and Health Condition, 1996-2016," was published in the latest issue of JAMA today.

Rosetta Genomics reports revenues of $150,000 for full-year 2009

Rosetta Genomics, Ltd., a leading developer of microRNA-based molecular diagnostics, today reported that on March 26, 2010 the Company filed its Form 20-F with the U.S. Securities and Exchange Committee, which contains financial results for the three and 12 months ended December 31, 2009.

Third case of monkey pox confirmed in UK

Officials from Public Health England (PHE) have confirmed yesterday (26th September 2018) that a third person in UK has been diagnosed with monkey pox. While the first two patients had most likely picked up the infection from Nigeria, this third infection has occurred in a healthcare worker who was treating one of the first two infected patients at Blackpool Victoria Hospital.

Johns Hopkins researchers discover oxaliplatin-based nerve damage

Oxaliplatin, a platinum-based anticancer drug that's made enormous headway in recent years against colorectal cancer, appears to cause nerve damage that may be permanent and worsens even months after treatment ends.

Read more Medical News

› Verified 1 days ago

Provider NameShaunquette V Garrett
Provider TypePractitioner - Clinical Social Worker
Provider IdentifiersNPI Number: 1669146940
PECOS PAC ID: 5799189130
Enrollment ID: I20210809000255

News Archive

New Cornell discovery could lead to effective treatment for tuberculosis

A recent discovery by Cornell University researchers could lead to a new, effective treatment for persistent tuberculosis infections.

A new report on health spending by Americans

There have been several studies showing that spending on health by Americans is on the rise, and around 18 percent of the US economy is individual spending on health. A study titled, "US Health Care Spending by Payer and Health Condition, 1996-2016," was published in the latest issue of JAMA today.

Rosetta Genomics reports revenues of $150,000 for full-year 2009

Rosetta Genomics, Ltd., a leading developer of microRNA-based molecular diagnostics, today reported that on March 26, 2010 the Company filed its Form 20-F with the U.S. Securities and Exchange Committee, which contains financial results for the three and 12 months ended December 31, 2009.

Third case of monkey pox confirmed in UK

Officials from Public Health England (PHE) have confirmed yesterday (26th September 2018) that a third person in UK has been diagnosed with monkey pox. While the first two patients had most likely picked up the infection from Nigeria, this third infection has occurred in a healthcare worker who was treating one of the first two infected patients at Blackpool Victoria Hospital.

Johns Hopkins researchers discover oxaliplatin-based nerve damage

Oxaliplatin, a platinum-based anticancer drug that's made enormous headway in recent years against colorectal cancer, appears to cause nerve damage that may be permanent and worsens even months after treatment ends.

Read more Medical News

› Verified 1 days ago

Provider NameMichelle Jones
Provider TypePractitioner - Clinical Social Worker
Provider IdentifiersNPI Number: 1629527163
PECOS PAC ID: 3779989306
Enrollment ID: I20210908000906

News Archive

New Cornell discovery could lead to effective treatment for tuberculosis

A recent discovery by Cornell University researchers could lead to a new, effective treatment for persistent tuberculosis infections.

A new report on health spending by Americans

There have been several studies showing that spending on health by Americans is on the rise, and around 18 percent of the US economy is individual spending on health. A study titled, "US Health Care Spending by Payer and Health Condition, 1996-2016," was published in the latest issue of JAMA today.

Rosetta Genomics reports revenues of $150,000 for full-year 2009

Rosetta Genomics, Ltd., a leading developer of microRNA-based molecular diagnostics, today reported that on March 26, 2010 the Company filed its Form 20-F with the U.S. Securities and Exchange Committee, which contains financial results for the three and 12 months ended December 31, 2009.

Third case of monkey pox confirmed in UK

Officials from Public Health England (PHE) have confirmed yesterday (26th September 2018) that a third person in UK has been diagnosed with monkey pox. While the first two patients had most likely picked up the infection from Nigeria, this third infection has occurred in a healthcare worker who was treating one of the first two infected patients at Blackpool Victoria Hospital.

Johns Hopkins researchers discover oxaliplatin-based nerve damage

Oxaliplatin, a platinum-based anticancer drug that's made enormous headway in recent years against colorectal cancer, appears to cause nerve damage that may be permanent and worsens even months after treatment ends.

Read more Medical News

› Verified 1 days ago

Provider NameJennifer Rose Iruegas
Provider TypePractitioner - Clinical Social Worker
Provider IdentifiersNPI Number: 1295402865
PECOS PAC ID: 0143614289
Enrollment ID: I20220307000436

News Archive

New Cornell discovery could lead to effective treatment for tuberculosis

A recent discovery by Cornell University researchers could lead to a new, effective treatment for persistent tuberculosis infections.

A new report on health spending by Americans

There have been several studies showing that spending on health by Americans is on the rise, and around 18 percent of the US economy is individual spending on health. A study titled, "US Health Care Spending by Payer and Health Condition, 1996-2016," was published in the latest issue of JAMA today.

Rosetta Genomics reports revenues of $150,000 for full-year 2009

Rosetta Genomics, Ltd., a leading developer of microRNA-based molecular diagnostics, today reported that on March 26, 2010 the Company filed its Form 20-F with the U.S. Securities and Exchange Committee, which contains financial results for the three and 12 months ended December 31, 2009.

Third case of monkey pox confirmed in UK

Officials from Public Health England (PHE) have confirmed yesterday (26th September 2018) that a third person in UK has been diagnosed with monkey pox. While the first two patients had most likely picked up the infection from Nigeria, this third infection has occurred in a healthcare worker who was treating one of the first two infected patients at Blackpool Victoria Hospital.

Johns Hopkins researchers discover oxaliplatin-based nerve damage

Oxaliplatin, a platinum-based anticancer drug that's made enormous headway in recent years against colorectal cancer, appears to cause nerve damage that may be permanent and worsens even months after treatment ends.

Read more Medical News

› Verified 1 days ago

Provider NameLisa Marie Foerster
Provider TypePractitioner - Clinical Social Worker
Provider IdentifiersNPI Number: 1275288607
PECOS PAC ID: 9739573726
Enrollment ID: I20220309000737

News Archive

New Cornell discovery could lead to effective treatment for tuberculosis

A recent discovery by Cornell University researchers could lead to a new, effective treatment for persistent tuberculosis infections.

A new report on health spending by Americans

There have been several studies showing that spending on health by Americans is on the rise, and around 18 percent of the US economy is individual spending on health. A study titled, "US Health Care Spending by Payer and Health Condition, 1996-2016," was published in the latest issue of JAMA today.

Rosetta Genomics reports revenues of $150,000 for full-year 2009

Rosetta Genomics, Ltd., a leading developer of microRNA-based molecular diagnostics, today reported that on March 26, 2010 the Company filed its Form 20-F with the U.S. Securities and Exchange Committee, which contains financial results for the three and 12 months ended December 31, 2009.

Third case of monkey pox confirmed in UK

Officials from Public Health England (PHE) have confirmed yesterday (26th September 2018) that a third person in UK has been diagnosed with monkey pox. While the first two patients had most likely picked up the infection from Nigeria, this third infection has occurred in a healthcare worker who was treating one of the first two infected patients at Blackpool Victoria Hospital.

Johns Hopkins researchers discover oxaliplatin-based nerve damage

Oxaliplatin, a platinum-based anticancer drug that's made enormous headway in recent years against colorectal cancer, appears to cause nerve damage that may be permanent and worsens even months after treatment ends.

Read more Medical News

› Verified 1 days ago

Provider NameBeyinah Y Hopkins
Provider TypePractitioner - Clinical Social Worker
Provider IdentifiersNPI Number: 1871078659
PECOS PAC ID: 4082000849
Enrollment ID: I20220404000212

News Archive

New Cornell discovery could lead to effective treatment for tuberculosis

A recent discovery by Cornell University researchers could lead to a new, effective treatment for persistent tuberculosis infections.

A new report on health spending by Americans

There have been several studies showing that spending on health by Americans is on the rise, and around 18 percent of the US economy is individual spending on health. A study titled, "US Health Care Spending by Payer and Health Condition, 1996-2016," was published in the latest issue of JAMA today.

Rosetta Genomics reports revenues of $150,000 for full-year 2009

Rosetta Genomics, Ltd., a leading developer of microRNA-based molecular diagnostics, today reported that on March 26, 2010 the Company filed its Form 20-F with the U.S. Securities and Exchange Committee, which contains financial results for the three and 12 months ended December 31, 2009.

Third case of monkey pox confirmed in UK

Officials from Public Health England (PHE) have confirmed yesterday (26th September 2018) that a third person in UK has been diagnosed with monkey pox. While the first two patients had most likely picked up the infection from Nigeria, this third infection has occurred in a healthcare worker who was treating one of the first two infected patients at Blackpool Victoria Hospital.

Johns Hopkins researchers discover oxaliplatin-based nerve damage

Oxaliplatin, a platinum-based anticancer drug that's made enormous headway in recent years against colorectal cancer, appears to cause nerve damage that may be permanent and worsens even months after treatment ends.

Read more Medical News

› Verified 1 days ago

Provider NameDiana Lambrecht
Provider TypePractitioner - Clinical Social Worker
Provider IdentifiersNPI Number: 1003559477
PECOS PAC ID: 2769879154
Enrollment ID: I20220504001170

News Archive

New Cornell discovery could lead to effective treatment for tuberculosis

A recent discovery by Cornell University researchers could lead to a new, effective treatment for persistent tuberculosis infections.

A new report on health spending by Americans

There have been several studies showing that spending on health by Americans is on the rise, and around 18 percent of the US economy is individual spending on health. A study titled, "US Health Care Spending by Payer and Health Condition, 1996-2016," was published in the latest issue of JAMA today.

Rosetta Genomics reports revenues of $150,000 for full-year 2009

Rosetta Genomics, Ltd., a leading developer of microRNA-based molecular diagnostics, today reported that on March 26, 2010 the Company filed its Form 20-F with the U.S. Securities and Exchange Committee, which contains financial results for the three and 12 months ended December 31, 2009.

Third case of monkey pox confirmed in UK

Officials from Public Health England (PHE) have confirmed yesterday (26th September 2018) that a third person in UK has been diagnosed with monkey pox. While the first two patients had most likely picked up the infection from Nigeria, this third infection has occurred in a healthcare worker who was treating one of the first two infected patients at Blackpool Victoria Hospital.

Johns Hopkins researchers discover oxaliplatin-based nerve damage

Oxaliplatin, a platinum-based anticancer drug that's made enormous headway in recent years against colorectal cancer, appears to cause nerve damage that may be permanent and worsens even months after treatment ends.

Read more Medical News

› Verified 1 days ago

Provider NameMichael Thomas Serpa
Provider TypePractitioner - Clinical Social Worker
Provider IdentifiersNPI Number: 1174897128
PECOS PAC ID: 3072991090
Enrollment ID: I20220603001218

News Archive

New Cornell discovery could lead to effective treatment for tuberculosis

A recent discovery by Cornell University researchers could lead to a new, effective treatment for persistent tuberculosis infections.

A new report on health spending by Americans

There have been several studies showing that spending on health by Americans is on the rise, and around 18 percent of the US economy is individual spending on health. A study titled, "US Health Care Spending by Payer and Health Condition, 1996-2016," was published in the latest issue of JAMA today.

Rosetta Genomics reports revenues of $150,000 for full-year 2009

Rosetta Genomics, Ltd., a leading developer of microRNA-based molecular diagnostics, today reported that on March 26, 2010 the Company filed its Form 20-F with the U.S. Securities and Exchange Committee, which contains financial results for the three and 12 months ended December 31, 2009.

Third case of monkey pox confirmed in UK

Officials from Public Health England (PHE) have confirmed yesterday (26th September 2018) that a third person in UK has been diagnosed with monkey pox. While the first two patients had most likely picked up the infection from Nigeria, this third infection has occurred in a healthcare worker who was treating one of the first two infected patients at Blackpool Victoria Hospital.

Johns Hopkins researchers discover oxaliplatin-based nerve damage

Oxaliplatin, a platinum-based anticancer drug that's made enormous headway in recent years against colorectal cancer, appears to cause nerve damage that may be permanent and worsens even months after treatment ends.

Read more Medical News

› Verified 1 days ago

Provider NameMonica Benetta Rodriguez
Provider TypePractitioner - Clinical Social Worker
Provider IdentifiersNPI Number: 1396863320
PECOS PAC ID: 4385554765
Enrollment ID: I20220617000608

News Archive

New Cornell discovery could lead to effective treatment for tuberculosis

A recent discovery by Cornell University researchers could lead to a new, effective treatment for persistent tuberculosis infections.

A new report on health spending by Americans

There have been several studies showing that spending on health by Americans is on the rise, and around 18 percent of the US economy is individual spending on health. A study titled, "US Health Care Spending by Payer and Health Condition, 1996-2016," was published in the latest issue of JAMA today.

Rosetta Genomics reports revenues of $150,000 for full-year 2009

Rosetta Genomics, Ltd., a leading developer of microRNA-based molecular diagnostics, today reported that on March 26, 2010 the Company filed its Form 20-F with the U.S. Securities and Exchange Committee, which contains financial results for the three and 12 months ended December 31, 2009.

Third case of monkey pox confirmed in UK

Officials from Public Health England (PHE) have confirmed yesterday (26th September 2018) that a third person in UK has been diagnosed with monkey pox. While the first two patients had most likely picked up the infection from Nigeria, this third infection has occurred in a healthcare worker who was treating one of the first two infected patients at Blackpool Victoria Hospital.

Johns Hopkins researchers discover oxaliplatin-based nerve damage

Oxaliplatin, a platinum-based anticancer drug that's made enormous headway in recent years against colorectal cancer, appears to cause nerve damage that may be permanent and worsens even months after treatment ends.

Read more Medical News

› Verified 1 days ago

Provider NameJasmine Casanova
Provider TypePractitioner - Clinical Social Worker
Provider IdentifiersNPI Number: 1750787107
PECOS PAC ID: 7517346455
Enrollment ID: I20220622003428

News Archive

New Cornell discovery could lead to effective treatment for tuberculosis

A recent discovery by Cornell University researchers could lead to a new, effective treatment for persistent tuberculosis infections.

A new report on health spending by Americans

There have been several studies showing that spending on health by Americans is on the rise, and around 18 percent of the US economy is individual spending on health. A study titled, "US Health Care Spending by Payer and Health Condition, 1996-2016," was published in the latest issue of JAMA today.

Rosetta Genomics reports revenues of $150,000 for full-year 2009

Rosetta Genomics, Ltd., a leading developer of microRNA-based molecular diagnostics, today reported that on March 26, 2010 the Company filed its Form 20-F with the U.S. Securities and Exchange Committee, which contains financial results for the three and 12 months ended December 31, 2009.

Third case of monkey pox confirmed in UK

Officials from Public Health England (PHE) have confirmed yesterday (26th September 2018) that a third person in UK has been diagnosed with monkey pox. While the first two patients had most likely picked up the infection from Nigeria, this third infection has occurred in a healthcare worker who was treating one of the first two infected patients at Blackpool Victoria Hospital.

Johns Hopkins researchers discover oxaliplatin-based nerve damage

Oxaliplatin, a platinum-based anticancer drug that's made enormous headway in recent years against colorectal cancer, appears to cause nerve damage that may be permanent and worsens even months after treatment ends.

Read more Medical News

› Verified 1 days ago

Provider NameKecia Harris
Provider TypePractitioner - Clinical Social Worker
Provider IdentifiersNPI Number: 1922540517
PECOS PAC ID: 8729467618
Enrollment ID: I20220623001710

News Archive

New Cornell discovery could lead to effective treatment for tuberculosis

A recent discovery by Cornell University researchers could lead to a new, effective treatment for persistent tuberculosis infections.

A new report on health spending by Americans

There have been several studies showing that spending on health by Americans is on the rise, and around 18 percent of the US economy is individual spending on health. A study titled, "US Health Care Spending by Payer and Health Condition, 1996-2016," was published in the latest issue of JAMA today.

Rosetta Genomics reports revenues of $150,000 for full-year 2009

Rosetta Genomics, Ltd., a leading developer of microRNA-based molecular diagnostics, today reported that on March 26, 2010 the Company filed its Form 20-F with the U.S. Securities and Exchange Committee, which contains financial results for the three and 12 months ended December 31, 2009.

Third case of monkey pox confirmed in UK

Officials from Public Health England (PHE) have confirmed yesterday (26th September 2018) that a third person in UK has been diagnosed with monkey pox. While the first two patients had most likely picked up the infection from Nigeria, this third infection has occurred in a healthcare worker who was treating one of the first two infected patients at Blackpool Victoria Hospital.

Johns Hopkins researchers discover oxaliplatin-based nerve damage

Oxaliplatin, a platinum-based anticancer drug that's made enormous headway in recent years against colorectal cancer, appears to cause nerve damage that may be permanent and worsens even months after treatment ends.

Read more Medical News

› Verified 1 days ago

Provider NamePedro A Villarreal
Provider TypePractitioner - Clinical Social Worker
Provider IdentifiersNPI Number: 1073073615
PECOS PAC ID: 9830571579
Enrollment ID: I20220728000121

News Archive

New Cornell discovery could lead to effective treatment for tuberculosis

A recent discovery by Cornell University researchers could lead to a new, effective treatment for persistent tuberculosis infections.

A new report on health spending by Americans

There have been several studies showing that spending on health by Americans is on the rise, and around 18 percent of the US economy is individual spending on health. A study titled, "US Health Care Spending by Payer and Health Condition, 1996-2016," was published in the latest issue of JAMA today.

Rosetta Genomics reports revenues of $150,000 for full-year 2009

Rosetta Genomics, Ltd., a leading developer of microRNA-based molecular diagnostics, today reported that on March 26, 2010 the Company filed its Form 20-F with the U.S. Securities and Exchange Committee, which contains financial results for the three and 12 months ended December 31, 2009.

Third case of monkey pox confirmed in UK

Officials from Public Health England (PHE) have confirmed yesterday (26th September 2018) that a third person in UK has been diagnosed with monkey pox. While the first two patients had most likely picked up the infection from Nigeria, this third infection has occurred in a healthcare worker who was treating one of the first two infected patients at Blackpool Victoria Hospital.

Johns Hopkins researchers discover oxaliplatin-based nerve damage

Oxaliplatin, a platinum-based anticancer drug that's made enormous headway in recent years against colorectal cancer, appears to cause nerve damage that may be permanent and worsens even months after treatment ends.

Read more Medical News

› Verified 1 days ago

Provider NameAdrian Rives
Provider TypePractitioner - Clinical Social Worker
Provider IdentifiersNPI Number: 1285369082
PECOS PAC ID: 7416339437
Enrollment ID: I20220808000036

News Archive

New Cornell discovery could lead to effective treatment for tuberculosis

A recent discovery by Cornell University researchers could lead to a new, effective treatment for persistent tuberculosis infections.

A new report on health spending by Americans

There have been several studies showing that spending on health by Americans is on the rise, and around 18 percent of the US economy is individual spending on health. A study titled, "US Health Care Spending by Payer and Health Condition, 1996-2016," was published in the latest issue of JAMA today.

Rosetta Genomics reports revenues of $150,000 for full-year 2009

Rosetta Genomics, Ltd., a leading developer of microRNA-based molecular diagnostics, today reported that on March 26, 2010 the Company filed its Form 20-F with the U.S. Securities and Exchange Committee, which contains financial results for the three and 12 months ended December 31, 2009.

Third case of monkey pox confirmed in UK

Officials from Public Health England (PHE) have confirmed yesterday (26th September 2018) that a third person in UK has been diagnosed with monkey pox. While the first two patients had most likely picked up the infection from Nigeria, this third infection has occurred in a healthcare worker who was treating one of the first two infected patients at Blackpool Victoria Hospital.

Johns Hopkins researchers discover oxaliplatin-based nerve damage

Oxaliplatin, a platinum-based anticancer drug that's made enormous headway in recent years against colorectal cancer, appears to cause nerve damage that may be permanent and worsens even months after treatment ends.

Read more Medical News

› Verified 1 days ago

Provider NameKathleen Pratt
Provider TypePractitioner - Clinical Social Worker
Provider IdentifiersNPI Number: 1407254709
PECOS PAC ID: 1759764558
Enrollment ID: I20220811001055

News Archive

New Cornell discovery could lead to effective treatment for tuberculosis

A recent discovery by Cornell University researchers could lead to a new, effective treatment for persistent tuberculosis infections.

A new report on health spending by Americans

There have been several studies showing that spending on health by Americans is on the rise, and around 18 percent of the US economy is individual spending on health. A study titled, "US Health Care Spending by Payer and Health Condition, 1996-2016," was published in the latest issue of JAMA today.

Rosetta Genomics reports revenues of $150,000 for full-year 2009

Rosetta Genomics, Ltd., a leading developer of microRNA-based molecular diagnostics, today reported that on March 26, 2010 the Company filed its Form 20-F with the U.S. Securities and Exchange Committee, which contains financial results for the three and 12 months ended December 31, 2009.

Third case of monkey pox confirmed in UK

Officials from Public Health England (PHE) have confirmed yesterday (26th September 2018) that a third person in UK has been diagnosed with monkey pox. While the first two patients had most likely picked up the infection from Nigeria, this third infection has occurred in a healthcare worker who was treating one of the first two infected patients at Blackpool Victoria Hospital.

Johns Hopkins researchers discover oxaliplatin-based nerve damage

Oxaliplatin, a platinum-based anticancer drug that's made enormous headway in recent years against colorectal cancer, appears to cause nerve damage that may be permanent and worsens even months after treatment ends.

Read more Medical News

› Verified 1 days ago

Provider NameMarilyn Joan Ladin
Provider TypePractitioner - Clinical Social Worker
Provider IdentifiersNPI Number: 1336490523
PECOS PAC ID: 0042695439
Enrollment ID: I20220921002431

News Archive

New Cornell discovery could lead to effective treatment for tuberculosis

A recent discovery by Cornell University researchers could lead to a new, effective treatment for persistent tuberculosis infections.

A new report on health spending by Americans

There have been several studies showing that spending on health by Americans is on the rise, and around 18 percent of the US economy is individual spending on health. A study titled, "US Health Care Spending by Payer and Health Condition, 1996-2016," was published in the latest issue of JAMA today.

Rosetta Genomics reports revenues of $150,000 for full-year 2009

Rosetta Genomics, Ltd., a leading developer of microRNA-based molecular diagnostics, today reported that on March 26, 2010 the Company filed its Form 20-F with the U.S. Securities and Exchange Committee, which contains financial results for the three and 12 months ended December 31, 2009.

Third case of monkey pox confirmed in UK

Officials from Public Health England (PHE) have confirmed yesterday (26th September 2018) that a third person in UK has been diagnosed with monkey pox. While the first two patients had most likely picked up the infection from Nigeria, this third infection has occurred in a healthcare worker who was treating one of the first two infected patients at Blackpool Victoria Hospital.

Johns Hopkins researchers discover oxaliplatin-based nerve damage

Oxaliplatin, a platinum-based anticancer drug that's made enormous headway in recent years against colorectal cancer, appears to cause nerve damage that may be permanent and worsens even months after treatment ends.

Read more Medical News

› Verified 1 days ago

Provider NameJazmanika Ikiah Maria Smith
Provider TypePractitioner - Clinical Social Worker
Provider IdentifiersNPI Number: 1285019489
PECOS PAC ID: 5597141424
Enrollment ID: I20220929004045

News Archive

New Cornell discovery could lead to effective treatment for tuberculosis

A recent discovery by Cornell University researchers could lead to a new, effective treatment for persistent tuberculosis infections.

A new report on health spending by Americans

There have been several studies showing that spending on health by Americans is on the rise, and around 18 percent of the US economy is individual spending on health. A study titled, "US Health Care Spending by Payer and Health Condition, 1996-2016," was published in the latest issue of JAMA today.

Rosetta Genomics reports revenues of $150,000 for full-year 2009

Rosetta Genomics, Ltd., a leading developer of microRNA-based molecular diagnostics, today reported that on March 26, 2010 the Company filed its Form 20-F with the U.S. Securities and Exchange Committee, which contains financial results for the three and 12 months ended December 31, 2009.

Third case of monkey pox confirmed in UK

Officials from Public Health England (PHE) have confirmed yesterday (26th September 2018) that a third person in UK has been diagnosed with monkey pox. While the first two patients had most likely picked up the infection from Nigeria, this third infection has occurred in a healthcare worker who was treating one of the first two infected patients at Blackpool Victoria Hospital.

Johns Hopkins researchers discover oxaliplatin-based nerve damage

Oxaliplatin, a platinum-based anticancer drug that's made enormous headway in recent years against colorectal cancer, appears to cause nerve damage that may be permanent and worsens even months after treatment ends.

Read more Medical News

› Verified 1 days ago

Provider NameMiyori T Pullen
Provider TypePractitioner - Clinical Social Worker
Provider IdentifiersNPI Number: 1831813781
PECOS PAC ID: 0143696278
Enrollment ID: I20221014001512

News Archive

New Cornell discovery could lead to effective treatment for tuberculosis

A recent discovery by Cornell University researchers could lead to a new, effective treatment for persistent tuberculosis infections.

A new report on health spending by Americans

There have been several studies showing that spending on health by Americans is on the rise, and around 18 percent of the US economy is individual spending on health. A study titled, "US Health Care Spending by Payer and Health Condition, 1996-2016," was published in the latest issue of JAMA today.

Rosetta Genomics reports revenues of $150,000 for full-year 2009

Rosetta Genomics, Ltd., a leading developer of microRNA-based molecular diagnostics, today reported that on March 26, 2010 the Company filed its Form 20-F with the U.S. Securities and Exchange Committee, which contains financial results for the three and 12 months ended December 31, 2009.

Third case of monkey pox confirmed in UK

Officials from Public Health England (PHE) have confirmed yesterday (26th September 2018) that a third person in UK has been diagnosed with monkey pox. While the first two patients had most likely picked up the infection from Nigeria, this third infection has occurred in a healthcare worker who was treating one of the first two infected patients at Blackpool Victoria Hospital.

Johns Hopkins researchers discover oxaliplatin-based nerve damage

Oxaliplatin, a platinum-based anticancer drug that's made enormous headway in recent years against colorectal cancer, appears to cause nerve damage that may be permanent and worsens even months after treatment ends.

Read more Medical News

› Verified 1 days ago

Provider NameLisa Davila
Provider TypePractitioner - Clinical Social Worker
Provider IdentifiersNPI Number: 1467632208
PECOS PAC ID: 4486020260
Enrollment ID: I20221019001388

News Archive

New Cornell discovery could lead to effective treatment for tuberculosis

A recent discovery by Cornell University researchers could lead to a new, effective treatment for persistent tuberculosis infections.

A new report on health spending by Americans

There have been several studies showing that spending on health by Americans is on the rise, and around 18 percent of the US economy is individual spending on health. A study titled, "US Health Care Spending by Payer and Health Condition, 1996-2016," was published in the latest issue of JAMA today.

Rosetta Genomics reports revenues of $150,000 for full-year 2009

Rosetta Genomics, Ltd., a leading developer of microRNA-based molecular diagnostics, today reported that on March 26, 2010 the Company filed its Form 20-F with the U.S. Securities and Exchange Committee, which contains financial results for the three and 12 months ended December 31, 2009.

Third case of monkey pox confirmed in UK

Officials from Public Health England (PHE) have confirmed yesterday (26th September 2018) that a third person in UK has been diagnosed with monkey pox. While the first two patients had most likely picked up the infection from Nigeria, this third infection has occurred in a healthcare worker who was treating one of the first two infected patients at Blackpool Victoria Hospital.

Johns Hopkins researchers discover oxaliplatin-based nerve damage

Oxaliplatin, a platinum-based anticancer drug that's made enormous headway in recent years against colorectal cancer, appears to cause nerve damage that may be permanent and worsens even months after treatment ends.

Read more Medical News

› Verified 1 days ago

Provider NamePamela Theresa Courseault
Provider TypePractitioner - Clinical Social Worker
Provider IdentifiersNPI Number: 1295407542
PECOS PAC ID: 7810365897
Enrollment ID: I20221122003273

News Archive

New Cornell discovery could lead to effective treatment for tuberculosis

A recent discovery by Cornell University researchers could lead to a new, effective treatment for persistent tuberculosis infections.

A new report on health spending by Americans

There have been several studies showing that spending on health by Americans is on the rise, and around 18 percent of the US economy is individual spending on health. A study titled, "US Health Care Spending by Payer and Health Condition, 1996-2016," was published in the latest issue of JAMA today.

Rosetta Genomics reports revenues of $150,000 for full-year 2009

Rosetta Genomics, Ltd., a leading developer of microRNA-based molecular diagnostics, today reported that on March 26, 2010 the Company filed its Form 20-F with the U.S. Securities and Exchange Committee, which contains financial results for the three and 12 months ended December 31, 2009.

Third case of monkey pox confirmed in UK

Officials from Public Health England (PHE) have confirmed yesterday (26th September 2018) that a third person in UK has been diagnosed with monkey pox. While the first two patients had most likely picked up the infection from Nigeria, this third infection has occurred in a healthcare worker who was treating one of the first two infected patients at Blackpool Victoria Hospital.

Johns Hopkins researchers discover oxaliplatin-based nerve damage

Oxaliplatin, a platinum-based anticancer drug that's made enormous headway in recent years against colorectal cancer, appears to cause nerve damage that may be permanent and worsens even months after treatment ends.

Read more Medical News

› Verified 1 days ago

Provider NameTreneva A Butler
Provider TypePractitioner - Clinical Social Worker
Provider IdentifiersNPI Number: 1740580901
PECOS PAC ID: 9234507120
Enrollment ID: I20221128001071

News Archive

New Cornell discovery could lead to effective treatment for tuberculosis

A recent discovery by Cornell University researchers could lead to a new, effective treatment for persistent tuberculosis infections.

A new report on health spending by Americans

There have been several studies showing that spending on health by Americans is on the rise, and around 18 percent of the US economy is individual spending on health. A study titled, "US Health Care Spending by Payer and Health Condition, 1996-2016," was published in the latest issue of JAMA today.

Rosetta Genomics reports revenues of $150,000 for full-year 2009

Rosetta Genomics, Ltd., a leading developer of microRNA-based molecular diagnostics, today reported that on March 26, 2010 the Company filed its Form 20-F with the U.S. Securities and Exchange Committee, which contains financial results for the three and 12 months ended December 31, 2009.

Third case of monkey pox confirmed in UK

Officials from Public Health England (PHE) have confirmed yesterday (26th September 2018) that a third person in UK has been diagnosed with monkey pox. While the first two patients had most likely picked up the infection from Nigeria, this third infection has occurred in a healthcare worker who was treating one of the first two infected patients at Blackpool Victoria Hospital.

Johns Hopkins researchers discover oxaliplatin-based nerve damage

Oxaliplatin, a platinum-based anticancer drug that's made enormous headway in recent years against colorectal cancer, appears to cause nerve damage that may be permanent and worsens even months after treatment ends.

Read more Medical News

› Verified 1 days ago

Provider NameBrandi Washington
Provider TypePractitioner - Clinical Social Worker
Provider IdentifiersNPI Number: 1699366294
PECOS PAC ID: 8820469786
Enrollment ID: I20230201000783

News Archive

New Cornell discovery could lead to effective treatment for tuberculosis

A recent discovery by Cornell University researchers could lead to a new, effective treatment for persistent tuberculosis infections.

A new report on health spending by Americans

There have been several studies showing that spending on health by Americans is on the rise, and around 18 percent of the US economy is individual spending on health. A study titled, "US Health Care Spending by Payer and Health Condition, 1996-2016," was published in the latest issue of JAMA today.

Rosetta Genomics reports revenues of $150,000 for full-year 2009

Rosetta Genomics, Ltd., a leading developer of microRNA-based molecular diagnostics, today reported that on March 26, 2010 the Company filed its Form 20-F with the U.S. Securities and Exchange Committee, which contains financial results for the three and 12 months ended December 31, 2009.

Third case of monkey pox confirmed in UK

Officials from Public Health England (PHE) have confirmed yesterday (26th September 2018) that a third person in UK has been diagnosed with monkey pox. While the first two patients had most likely picked up the infection from Nigeria, this third infection has occurred in a healthcare worker who was treating one of the first two infected patients at Blackpool Victoria Hospital.

Johns Hopkins researchers discover oxaliplatin-based nerve damage

Oxaliplatin, a platinum-based anticancer drug that's made enormous headway in recent years against colorectal cancer, appears to cause nerve damage that may be permanent and worsens even months after treatment ends.

Read more Medical News

› Verified 1 days ago

Provider NameLatasha Vanin
Provider TypePractitioner - Clinical Social Worker
Provider IdentifiersNPI Number: 1417340472
PECOS PAC ID: 0143694521
Enrollment ID: I20230327001234

News Archive

New Cornell discovery could lead to effective treatment for tuberculosis

A recent discovery by Cornell University researchers could lead to a new, effective treatment for persistent tuberculosis infections.

A new report on health spending by Americans

There have been several studies showing that spending on health by Americans is on the rise, and around 18 percent of the US economy is individual spending on health. A study titled, "US Health Care Spending by Payer and Health Condition, 1996-2016," was published in the latest issue of JAMA today.

Rosetta Genomics reports revenues of $150,000 for full-year 2009

Rosetta Genomics, Ltd., a leading developer of microRNA-based molecular diagnostics, today reported that on March 26, 2010 the Company filed its Form 20-F with the U.S. Securities and Exchange Committee, which contains financial results for the three and 12 months ended December 31, 2009.

Third case of monkey pox confirmed in UK

Officials from Public Health England (PHE) have confirmed yesterday (26th September 2018) that a third person in UK has been diagnosed with monkey pox. While the first two patients had most likely picked up the infection from Nigeria, this third infection has occurred in a healthcare worker who was treating one of the first two infected patients at Blackpool Victoria Hospital.

Johns Hopkins researchers discover oxaliplatin-based nerve damage

Oxaliplatin, a platinum-based anticancer drug that's made enormous headway in recent years against colorectal cancer, appears to cause nerve damage that may be permanent and worsens even months after treatment ends.

Read more Medical News

› Verified 1 days ago

Provider NameZasia Giddings
Provider TypePractitioner - Clinical Social Worker
Provider IdentifiersNPI Number: 1750094041
PECOS PAC ID: 1658746763
Enrollment ID: I20230403001552

News Archive

New Cornell discovery could lead to effective treatment for tuberculosis

A recent discovery by Cornell University researchers could lead to a new, effective treatment for persistent tuberculosis infections.

A new report on health spending by Americans

There have been several studies showing that spending on health by Americans is on the rise, and around 18 percent of the US economy is individual spending on health. A study titled, "US Health Care Spending by Payer and Health Condition, 1996-2016," was published in the latest issue of JAMA today.

Rosetta Genomics reports revenues of $150,000 for full-year 2009

Rosetta Genomics, Ltd., a leading developer of microRNA-based molecular diagnostics, today reported that on March 26, 2010 the Company filed its Form 20-F with the U.S. Securities and Exchange Committee, which contains financial results for the three and 12 months ended December 31, 2009.

Third case of monkey pox confirmed in UK

Officials from Public Health England (PHE) have confirmed yesterday (26th September 2018) that a third person in UK has been diagnosed with monkey pox. While the first two patients had most likely picked up the infection from Nigeria, this third infection has occurred in a healthcare worker who was treating one of the first two infected patients at Blackpool Victoria Hospital.

Johns Hopkins researchers discover oxaliplatin-based nerve damage

Oxaliplatin, a platinum-based anticancer drug that's made enormous headway in recent years against colorectal cancer, appears to cause nerve damage that may be permanent and worsens even months after treatment ends.

Read more Medical News

› Verified 1 days ago

Provider NameIda Ruiz
Provider TypePractitioner - Clinical Social Worker
Provider IdentifiersNPI Number: 1336853076
PECOS PAC ID: 3375918279
Enrollment ID: I20230406001215

News Archive

New Cornell discovery could lead to effective treatment for tuberculosis

A recent discovery by Cornell University researchers could lead to a new, effective treatment for persistent tuberculosis infections.

A new report on health spending by Americans

There have been several studies showing that spending on health by Americans is on the rise, and around 18 percent of the US economy is individual spending on health. A study titled, "US Health Care Spending by Payer and Health Condition, 1996-2016," was published in the latest issue of JAMA today.

Rosetta Genomics reports revenues of $150,000 for full-year 2009

Rosetta Genomics, Ltd., a leading developer of microRNA-based molecular diagnostics, today reported that on March 26, 2010 the Company filed its Form 20-F with the U.S. Securities and Exchange Committee, which contains financial results for the three and 12 months ended December 31, 2009.

Third case of monkey pox confirmed in UK

Officials from Public Health England (PHE) have confirmed yesterday (26th September 2018) that a third person in UK has been diagnosed with monkey pox. While the first two patients had most likely picked up the infection from Nigeria, this third infection has occurred in a healthcare worker who was treating one of the first two infected patients at Blackpool Victoria Hospital.

Johns Hopkins researchers discover oxaliplatin-based nerve damage

Oxaliplatin, a platinum-based anticancer drug that's made enormous headway in recent years against colorectal cancer, appears to cause nerve damage that may be permanent and worsens even months after treatment ends.

Read more Medical News

› Verified 1 days ago

Provider NameAurelio De La Fuente
Provider TypePractitioner - Clinical Social Worker
Provider IdentifiersNPI Number: 1366801722
PECOS PAC ID: 6103291505
Enrollment ID: I20230418001063

News Archive

New Cornell discovery could lead to effective treatment for tuberculosis

A recent discovery by Cornell University researchers could lead to a new, effective treatment for persistent tuberculosis infections.

A new report on health spending by Americans

There have been several studies showing that spending on health by Americans is on the rise, and around 18 percent of the US economy is individual spending on health. A study titled, "US Health Care Spending by Payer and Health Condition, 1996-2016," was published in the latest issue of JAMA today.

Rosetta Genomics reports revenues of $150,000 for full-year 2009

Rosetta Genomics, Ltd., a leading developer of microRNA-based molecular diagnostics, today reported that on March 26, 2010 the Company filed its Form 20-F with the U.S. Securities and Exchange Committee, which contains financial results for the three and 12 months ended December 31, 2009.

Third case of monkey pox confirmed in UK

Officials from Public Health England (PHE) have confirmed yesterday (26th September 2018) that a third person in UK has been diagnosed with monkey pox. While the first two patients had most likely picked up the infection from Nigeria, this third infection has occurred in a healthcare worker who was treating one of the first two infected patients at Blackpool Victoria Hospital.

Johns Hopkins researchers discover oxaliplatin-based nerve damage

Oxaliplatin, a platinum-based anticancer drug that's made enormous headway in recent years against colorectal cancer, appears to cause nerve damage that may be permanent and worsens even months after treatment ends.

Read more Medical News

› Verified 1 days ago

Provider NameJacquelyn A Moore
Provider TypePractitioner - Clinical Social Worker
Provider IdentifiersNPI Number: 1457133613
PECOS PAC ID: 6002264280
Enrollment ID: I20231128003803

News Archive

New Cornell discovery could lead to effective treatment for tuberculosis

A recent discovery by Cornell University researchers could lead to a new, effective treatment for persistent tuberculosis infections.

A new report on health spending by Americans

There have been several studies showing that spending on health by Americans is on the rise, and around 18 percent of the US economy is individual spending on health. A study titled, "US Health Care Spending by Payer and Health Condition, 1996-2016," was published in the latest issue of JAMA today.

Rosetta Genomics reports revenues of $150,000 for full-year 2009

Rosetta Genomics, Ltd., a leading developer of microRNA-based molecular diagnostics, today reported that on March 26, 2010 the Company filed its Form 20-F with the U.S. Securities and Exchange Committee, which contains financial results for the three and 12 months ended December 31, 2009.

Third case of monkey pox confirmed in UK

Officials from Public Health England (PHE) have confirmed yesterday (26th September 2018) that a third person in UK has been diagnosed with monkey pox. While the first two patients had most likely picked up the infection from Nigeria, this third infection has occurred in a healthcare worker who was treating one of the first two infected patients at Blackpool Victoria Hospital.

Johns Hopkins researchers discover oxaliplatin-based nerve damage

Oxaliplatin, a platinum-based anticancer drug that's made enormous headway in recent years against colorectal cancer, appears to cause nerve damage that may be permanent and worsens even months after treatment ends.

Read more Medical News

› Verified 1 days ago

Provider NameJennifer D Moore
Provider TypePractitioner - Clinical Social Worker
Provider IdentifiersNPI Number: 1922873926
PECOS PAC ID: 5294184412
Enrollment ID: I20231213003788

News Archive

New Cornell discovery could lead to effective treatment for tuberculosis

A recent discovery by Cornell University researchers could lead to a new, effective treatment for persistent tuberculosis infections.

A new report on health spending by Americans

There have been several studies showing that spending on health by Americans is on the rise, and around 18 percent of the US economy is individual spending on health. A study titled, "US Health Care Spending by Payer and Health Condition, 1996-2016," was published in the latest issue of JAMA today.

Rosetta Genomics reports revenues of $150,000 for full-year 2009

Rosetta Genomics, Ltd., a leading developer of microRNA-based molecular diagnostics, today reported that on March 26, 2010 the Company filed its Form 20-F with the U.S. Securities and Exchange Committee, which contains financial results for the three and 12 months ended December 31, 2009.

Third case of monkey pox confirmed in UK

Officials from Public Health England (PHE) have confirmed yesterday (26th September 2018) that a third person in UK has been diagnosed with monkey pox. While the first two patients had most likely picked up the infection from Nigeria, this third infection has occurred in a healthcare worker who was treating one of the first two infected patients at Blackpool Victoria Hospital.

Johns Hopkins researchers discover oxaliplatin-based nerve damage

Oxaliplatin, a platinum-based anticancer drug that's made enormous headway in recent years against colorectal cancer, appears to cause nerve damage that may be permanent and worsens even months after treatment ends.

Read more Medical News

› Verified 1 days ago

Provider NameRobyn L Ott
Provider TypePractitioner - Clinical Social Worker
Provider IdentifiersNPI Number: 1174650469
PECOS PAC ID: 5597116301
Enrollment ID: I20240105002227

News Archive

New Cornell discovery could lead to effective treatment for tuberculosis

A recent discovery by Cornell University researchers could lead to a new, effective treatment for persistent tuberculosis infections.

A new report on health spending by Americans

There have been several studies showing that spending on health by Americans is on the rise, and around 18 percent of the US economy is individual spending on health. A study titled, "US Health Care Spending by Payer and Health Condition, 1996-2016," was published in the latest issue of JAMA today.

Rosetta Genomics reports revenues of $150,000 for full-year 2009

Rosetta Genomics, Ltd., a leading developer of microRNA-based molecular diagnostics, today reported that on March 26, 2010 the Company filed its Form 20-F with the U.S. Securities and Exchange Committee, which contains financial results for the three and 12 months ended December 31, 2009.

Third case of monkey pox confirmed in UK

Officials from Public Health England (PHE) have confirmed yesterday (26th September 2018) that a third person in UK has been diagnosed with monkey pox. While the first two patients had most likely picked up the infection from Nigeria, this third infection has occurred in a healthcare worker who was treating one of the first two infected patients at Blackpool Victoria Hospital.

Johns Hopkins researchers discover oxaliplatin-based nerve damage

Oxaliplatin, a platinum-based anticancer drug that's made enormous headway in recent years against colorectal cancer, appears to cause nerve damage that may be permanent and worsens even months after treatment ends.

Read more Medical News

› Verified 1 days ago

Provider NameRoberto Guerrero
Provider TypePractitioner - Mental Health Counselor
Provider IdentifiersNPI Number: 1164069589
PECOS PAC ID: 1951752484
Enrollment ID: I20240109004685

News Archive

New Cornell discovery could lead to effective treatment for tuberculosis

A recent discovery by Cornell University researchers could lead to a new, effective treatment for persistent tuberculosis infections.

A new report on health spending by Americans

There have been several studies showing that spending on health by Americans is on the rise, and around 18 percent of the US economy is individual spending on health. A study titled, "US Health Care Spending by Payer and Health Condition, 1996-2016," was published in the latest issue of JAMA today.

Rosetta Genomics reports revenues of $150,000 for full-year 2009

Rosetta Genomics, Ltd., a leading developer of microRNA-based molecular diagnostics, today reported that on March 26, 2010 the Company filed its Form 20-F with the U.S. Securities and Exchange Committee, which contains financial results for the three and 12 months ended December 31, 2009.

Third case of monkey pox confirmed in UK

Officials from Public Health England (PHE) have confirmed yesterday (26th September 2018) that a third person in UK has been diagnosed with monkey pox. While the first two patients had most likely picked up the infection from Nigeria, this third infection has occurred in a healthcare worker who was treating one of the first two infected patients at Blackpool Victoria Hospital.

Johns Hopkins researchers discover oxaliplatin-based nerve damage

Oxaliplatin, a platinum-based anticancer drug that's made enormous headway in recent years against colorectal cancer, appears to cause nerve damage that may be permanent and worsens even months after treatment ends.

Read more Medical News

› Verified 1 days ago

Provider NameCorrine Lashunda Rowe
Provider TypePractitioner - Clinical Social Worker
Provider IdentifiersNPI Number: 1760135800
PECOS PAC ID: 6709237936
Enrollment ID: I20240111002943

News Archive

New Cornell discovery could lead to effective treatment for tuberculosis

A recent discovery by Cornell University researchers could lead to a new, effective treatment for persistent tuberculosis infections.

A new report on health spending by Americans

There have been several studies showing that spending on health by Americans is on the rise, and around 18 percent of the US economy is individual spending on health. A study titled, "US Health Care Spending by Payer and Health Condition, 1996-2016," was published in the latest issue of JAMA today.

Rosetta Genomics reports revenues of $150,000 for full-year 2009

Rosetta Genomics, Ltd., a leading developer of microRNA-based molecular diagnostics, today reported that on March 26, 2010 the Company filed its Form 20-F with the U.S. Securities and Exchange Committee, which contains financial results for the three and 12 months ended December 31, 2009.

Third case of monkey pox confirmed in UK

Officials from Public Health England (PHE) have confirmed yesterday (26th September 2018) that a third person in UK has been diagnosed with monkey pox. While the first two patients had most likely picked up the infection from Nigeria, this third infection has occurred in a healthcare worker who was treating one of the first two infected patients at Blackpool Victoria Hospital.

Johns Hopkins researchers discover oxaliplatin-based nerve damage

Oxaliplatin, a platinum-based anticancer drug that's made enormous headway in recent years against colorectal cancer, appears to cause nerve damage that may be permanent and worsens even months after treatment ends.

Read more Medical News

› Verified 1 days ago

Provider NameKristina Kathleen Dupre
Provider TypePractitioner - Mental Health Counselor
Provider IdentifiersNPI Number: 1205574514
PECOS PAC ID: 6800249129
Enrollment ID: I20240201004167

News Archive

New Cornell discovery could lead to effective treatment for tuberculosis

A recent discovery by Cornell University researchers could lead to a new, effective treatment for persistent tuberculosis infections.

A new report on health spending by Americans

There have been several studies showing that spending on health by Americans is on the rise, and around 18 percent of the US economy is individual spending on health. A study titled, "US Health Care Spending by Payer and Health Condition, 1996-2016," was published in the latest issue of JAMA today.

Rosetta Genomics reports revenues of $150,000 for full-year 2009

Rosetta Genomics, Ltd., a leading developer of microRNA-based molecular diagnostics, today reported that on March 26, 2010 the Company filed its Form 20-F with the U.S. Securities and Exchange Committee, which contains financial results for the three and 12 months ended December 31, 2009.

Third case of monkey pox confirmed in UK

Officials from Public Health England (PHE) have confirmed yesterday (26th September 2018) that a third person in UK has been diagnosed with monkey pox. While the first two patients had most likely picked up the infection from Nigeria, this third infection has occurred in a healthcare worker who was treating one of the first two infected patients at Blackpool Victoria Hospital.

Johns Hopkins researchers discover oxaliplatin-based nerve damage

Oxaliplatin, a platinum-based anticancer drug that's made enormous headway in recent years against colorectal cancer, appears to cause nerve damage that may be permanent and worsens even months after treatment ends.

Read more Medical News

› Verified 1 days ago

Provider NameDana Irene Tamasi
Provider TypePractitioner - Clinical Social Worker
Provider IdentifiersNPI Number: 1285968388
PECOS PAC ID: 8022451657
Enrollment ID: I20240209003159

News Archive

New Cornell discovery could lead to effective treatment for tuberculosis

A recent discovery by Cornell University researchers could lead to a new, effective treatment for persistent tuberculosis infections.

A new report on health spending by Americans

There have been several studies showing that spending on health by Americans is on the rise, and around 18 percent of the US economy is individual spending on health. A study titled, "US Health Care Spending by Payer and Health Condition, 1996-2016," was published in the latest issue of JAMA today.

Rosetta Genomics reports revenues of $150,000 for full-year 2009

Rosetta Genomics, Ltd., a leading developer of microRNA-based molecular diagnostics, today reported that on March 26, 2010 the Company filed its Form 20-F with the U.S. Securities and Exchange Committee, which contains financial results for the three and 12 months ended December 31, 2009.

Third case of monkey pox confirmed in UK

Officials from Public Health England (PHE) have confirmed yesterday (26th September 2018) that a third person in UK has been diagnosed with monkey pox. While the first two patients had most likely picked up the infection from Nigeria, this third infection has occurred in a healthcare worker who was treating one of the first two infected patients at Blackpool Victoria Hospital.

Johns Hopkins researchers discover oxaliplatin-based nerve damage

Oxaliplatin, a platinum-based anticancer drug that's made enormous headway in recent years against colorectal cancer, appears to cause nerve damage that may be permanent and worsens even months after treatment ends.

Read more Medical News

› Verified 1 days ago

News Archive

New Cornell discovery could lead to effective treatment for tuberculosis

A recent discovery by Cornell University researchers could lead to a new, effective treatment for persistent tuberculosis infections.

A new report on health spending by Americans

There have been several studies showing that spending on health by Americans is on the rise, and around 18 percent of the US economy is individual spending on health. A study titled, "US Health Care Spending by Payer and Health Condition, 1996-2016," was published in the latest issue of JAMA today.

Rosetta Genomics reports revenues of $150,000 for full-year 2009

Rosetta Genomics, Ltd., a leading developer of microRNA-based molecular diagnostics, today reported that on March 26, 2010 the Company filed its Form 20-F with the U.S. Securities and Exchange Committee, which contains financial results for the three and 12 months ended December 31, 2009.

Third case of monkey pox confirmed in UK

Officials from Public Health England (PHE) have confirmed yesterday (26th September 2018) that a third person in UK has been diagnosed with monkey pox. While the first two patients had most likely picked up the infection from Nigeria, this third infection has occurred in a healthcare worker who was treating one of the first two infected patients at Blackpool Victoria Hospital.

Johns Hopkins researchers discover oxaliplatin-based nerve damage

Oxaliplatin, a platinum-based anticancer drug that's made enormous headway in recent years against colorectal cancer, appears to cause nerve damage that may be permanent and worsens even months after treatment ends.

Read more News

› Verified 1 days ago

Social Worker in Allen, TX

Behavioral Health Assessments
Mental Health Clinic
Medicare: Not Enrolled in Medicare
Practice Location: 1410 Glasgow Ln, Allen, TX 75013
Phone: 800-207-1592    
Reece Consulting Pllc
Mental Health Clinic
Medicare: Medicare Enrolled
Practice Location: 550 S Watters Rd Ste 136, Allen, TX 75013
Phone: 945-253-5195    Fax: 469-713-2432
Thompson Counseling And Family Therapy, Pllc
Mental Health Clinic
Medicare: Not Enrolled in Medicare
Practice Location: 1514 N Greenville Ave Ste 310, Allen, TX 75002
Phone: 972-679-2167    
American Healthcare Holdings Llc
Mental Health Clinic
Medicare: Not Enrolled in Medicare
Practice Location: 600 S Jupiter Rd Ste 150, Allen, TX 75002
Phone: 469-543-7674    Fax: 469-991-6777
Penny 4 Your Thoughts Counseling, Pllc
Mental Health Clinic
Medicare: Not Enrolled in Medicare
Practice Location: 550 S Watters Rd Ste 230, Allen, TX 75013
Phone: 214-415-0178    
Upswing Psychiatry
Mental Health Clinic
Medicare: Medicare Enrolled
Practice Location: 22 Prestige Circle, Suite 300, Allen, TX 75002
Phone: 214-383-3200    Fax: 214-383-3211
Great Pathways Psychiatry Pllc
Mental Health Clinic
Medicare: Not Enrolled in Medicare
Practice Location: 1333 W Mcdermott Dr Ste 200, Allen, TX 75013
Phone: 469-564-4211    Fax: 469-242-9719

Find & Compare Providers Near You: Find and compare doctors, nursing homes, hospitals, and other health care providers in your area that accept Medicare. Get information like: Find a doctor or clinician that accepts Medicare near you.

Doctors and clinicians: Doctors and clinicians include doctors, clinicians and groups who are qualified to practice in many specialties. Each specialty focuses on certain parts of the body, periods of life, conditions, or primary care. The doctors, clinicians, and groups listed here typically work in an office or clinic setting. Also those who currently accept Medicare are included.

Hospitals: Find information about Medicare-certified hospitals and long-term care hospitals in your area, including Veterans Administration medical centers and military hospitals, across the country. Long-term care hospitals serve critically ill and medically complex patients who require extended hospital care.

Data provided: Information on www.medicareusa.org is built using open data sources published by Centers for Medicare & Medicaid Services (CMS) under Freedom of Information Act (FOIA).

© 2024 MedicareUsa. All rights reserved. Maintained by the Agency for Healthcare Research and Quality, U.S. Department of Health and Human Services.